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PART I INTRODUCTION 
CHAPTER 1.1 Introduction 
CHAPTER 1.2 Aims of the investigations 
1.1 INTRODUCTION 
In the to-day's world an enormous activity is going on in 
synthetizing new chemical compounds. Although only few of them 
find their way into the society as industrial chemical, pesticide, 
food additive or drugs, man is exposed, intentionally or uninten-
tionally, to an increasing number of synthetic chemical products. 
Such compounds which are no natural constituents of living 
organisms, usually are called xenobiotics. It should be added 
that also quite a number of naturally occurring components belong 
to the class of xenobiotics. 
After such xenobiotic compounds have entered the body they 
are generally made more hydrophilic by biotransformation processes 
and subsequent conjugations. Thus, in this manner the 
solubility in' water is enhanced and therefore the elimination 
from the organism considerably facilitated. In vertebrates the 
liver is by far the most important organ with respect to the 
metabolism of xenobiotics. ^ However, biotransformation of 
xenobiotics in non-hepatic tissues should not be neglected. For 
instance, the drug metabolizing enzymes present in the gastro-
intestinal tract, lung or skin may be of particular importance in 
the disposition of foreign chemicals which have entered the body 
system through direct contact with environmental pollutants. 
Some of these xenobiotic materials may mediate a variety of 
toxicities, necrosis, allergic reactions and mutagenic or 
carcinogenic effects. Likely, they act by combining with vitally' 
important intracellular components such as tissue macromolecules 
like proteins, RNA and/or DNA by a reaction with nucleophilic 
sites. 
Xenobiotics that react with nucleophilic groups or sites in 
the living organism may be divided into two classes, viz. those 
that alkylate, arylate or acylate directly the cellular macro-
molecules and those that are initially chemically inert but are 
converted into electrophilic species by bioactivation. The latter 
compounds in fact are indirect alkylating agents. 
It should be noticed, however, that not all potential 
-7-
alkylating agents will bind covaiently to cellular macromolecules. 
The extent to which alkylation occurs depends on the balance of 
the different metabolizing enzyme systems in the particular cells 
and the reactivity of the intermediate towards critical targets in 
the cell macromolecules. Studies have indicated a crucial role for 
sulphydryl-containing compounds and in particular glutathione in 
protecting tissues against reactive electrophilic metabolites of 
xenobiotics. 3, 4 
Glutathione (GSH) is an endogenous t r i p e p t i d e , γ-g lutaminy l-
c y s t e i n y l - g l y c i n e , able to conjugate wi th a wide v a r i e t y of xeno­
b i o t i c s , which include epoxides, a lky l or a r a i k y l h a l i des, α,β-
unsaturated carbonyl compounds, and generally any compound 
possessing e l e c t r o p h i l i c propert ies. The remarkably broad spectrum 
of s t r u c t u r a l types which undergo conjugation w i t h GSH are 
Q fi 
described i n several e x c e l l e n t reviews on t h i s subject . " In 
most cases the conjugation is catalyzed by glutathione 
S-transferases, although some compounds conjugate spontaneously 
w i t h GSH. I t has been suggested that the act ive centre of 
g lutath ione S-transferase possesses two subunits, viz. one f o r 
GSH or the peptide moiety of GSH-derivati ves (G-site) and one f o r 
the hydrophobic groups i n the proximity of the sulphydryl group 
of enzyme bound GSH ( Η - s i t e ) , ( f i g u r e 1 ) . 
HO NH 
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Figure 1 Proposed structure of glutathione S-transferase 
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The lat ter si te is probably the binding si te for the substrate to 
be conjugated with GSH. The functional groups of the active s i t e , 
which participate in the catalytic events have not yet been 
ident i f ied. Probably a base which by deprotonation enhances the 
nucleophilicity of the sulphydryl group of GSH is a constituent 
of the catalyt ic machinery. Also an acid has been suggested to 
exert a catalyt ic effect. Through protonation of certain functio-
nal groups their leaving ab i l i ty in nucleophilic substitution 
reaction may be improved, or in other words protonation may 
enhance the electrophi l ic i ty of the substrate in i t s propensity 
to be conjugated. Furthermore, such an acid si te may serve as 
proton source in conjugation reactions of GSH with epoxides and 
alkene groups. 
These biotransformations are completed by further metaboli-
sation of the glutathione conjugate by enzymatic cleavage of the 
peptide bonds of the terminal amino acids, leaving a cysteine 
derivative. In a subsequent step this derivative is N-acetylated 
to afford an N-acetylcysteine conjugate, which are known as 
mercapturic acids. Usually these mercapturic acids are excreted 
via the urine. The general pathway of mercapturic acid formation 
is depicted in figure 2. 
Unsaturated xenobiotias 
In the context of this thesis particular attention w i l l be given 
to the biological fate of unsaturated aliphatic compounds (c . f . 
alkenes). 
Evidence has been accumulated that oxidative attack by the 
mixed-function oxidase system is an essential step in the bioact i -
o 
vation of olef in ic compounds. Mixed funation oxidase is the 
general term for a group of enzymes that play a central role in 
the biotransformation of many xenobiotics. The reactions they 
catalyze are oxidations and in some cases reductions. These 
enzymes are bound to the smooth endoplasmatic reticulum of the 
c e l l . The central part of the enzyme is a hemoprotein, viz. 
cytochrome P-450, deriving i ts name from the U.V. absorbance at 
- 9 -
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Figure 2 Mercapturic acid biosynthesis 
450 nm, when carbon monoxide is bound to i t . Cytochrome P-450 is 
able to transform compounds with a tremendous variation in g 
structure, l ike arenes, alkenes, amines and al kanes. The 
epoxidation of unsaturated compounds can take place with several 
systems containing a carbon-carbon double bond including those 
present in olef inic side chains, those having an exo-methylene 
- 1 0 -
group attached to a ring system, or those present in cyclic 
structures. Epoxidation of an unsaturated bond in an aromatic 
structure results in the formation of an arene oxide. It has been 
demonstrated that arene oxide formation is involved in the 
production of toxic and carcinogenic metabolites of many 
substances containing an aromatic substituent, particularly 
polycyclic aromatic hydrocarbons. Comprehensive reviews of the 
literature, especially dealing with arene oxides are 
available. ' During the epoxidation of olefinic compounds 
epoxides may be formed that exhibit a considerable chemical 
reactivity, also in the biosystem. Particularly, their behaviour 
as electrophiles in reactions with nucleophilic species should be 
noted. Consequently, olefinic compounds that are converted into a 
chemically reactive epoxide by a biotransformation process can be 
considered as indirect alkylating agents. On the other hand, 
compounds containing a double bond which is strongly polarized by 
electron withdrawing substituents such as carbonyl, nitrile, 
sul fone or nitro groups, belong to the class of direct alkylating 
agents. 
As indicated above reactive epoxides may exert toxic and 
mutagenic effects. Fortunately, in many instances the organism is 
capable to deactivate the reactive epoxide intermediates. One of 
these detoxifying mechanisms is conjugation with glutathione, 
previously described. Another detoxifying system is the epoxide 
hydrolase. Of this enzyme system two forms have been uncovered, 
12 13 
viz. a soluble enzyme and a microsomally bound one. The 
latter one has been more widely studied than the former. These 
enzymes catalyze the hydration of aromatic and olefinic epoxides 
14 to trans-vicinal diols. 
There are some indications that the microsomal epoxide 
hydrolase cooperates, at least partly, with the mixed function 
15 
oxidase. This would have important implications because 
epoxides formed via Cyt.P-450 may thus be converted directly 
into diols. 
The epoxides have to f u l f i l certain structural requirements in 
- 1 1 -
order to be accepted as substrates by the epoxide hydrolase. Mono 
substituted and l i l -d isubst i tu ted epoxides bearing at least one 
large l ipophi l ic group are among the best substrates. Cis-1,2-
disubstituted epoxides are also converted to d io ls , but not trans-
1,2-disubstituted epoxides and epoxides bearing three or four 
substituents. 
In addition to the herefore mentioned two enzymatically catalyzed 
reactions epoxides also may undergo a rearrangement reaction 
either spontaneous or catalyzed by a Lewis acid. The tendency to 
rearrange depends on the substituents attached to i t and probably 
also on the chemical circumstances at the place of formation of 
the epoxide. 
- 1 2 -
1.2 AIMS OF THE INVESTIGATIONS 
Knowledge of the pathways by which xenobiotics are metabolized is 
essential f o r a b e t t e r understanding of t h e i r mode of a c t i o n and 
of the processes f o r t h e i r d e t o x i f i c a t i o n . Conjugation w i t h 
glutathione const i tu tes an important d e t o x i f i c a t i o n route f o r 
many xenobiot ics. Often the occurrence of a react ive intermediate 
and subsequent glutathione conjugation can be deduced from the 
ur inary excret ion of a mercapturic a c i d . I d e n t i f i c a t i o n of 
glutathione conjugates and/or the corresponding mercapturic acids 
can provide informat ion on the exact nature of these b i o l o g i c a l l y 
act ive intermediates and even t h e i r immediate precursors. 
Establishment of the c h i r a l i t y of the excreted mercapturic acids 
provides the p o s s i b i l i t y to study the stereochemical course of 
glutathione conjugation in vivo. Furthermore, the use of a racemic 
mixture of c h i r a l substrates, i n which the c h i r a l centre is 
involved i n the conjugation r e a c t i o n , o f f e r s a means to gather 
i n s i g h t i n the degree of s t e r e o s e l e c t i v i t y of the substrate 
towards g lutath ione S-transferases. 
This thesis deals with the metabolism of o l e f i n i c conpounds 
carry ing a v a r i e t y of subst i tuents. As i t is known from the 
l i t e r a t u r e that styrene via a primary b io-ox idat ion to styrene 
oxide, is u l t i m a t e l y excreted i n the urine of rats as a mercapturic 
acid , t h i s compound was chosen as model substrate. The study 
was extended to alkenes bearing e lectron withdrawing 
s u b s t i t u e n t s , i n order to evaluate the inf luence of such 
substituents on the metabolic d i s p o s i t i o n . The f o l l o w i n g compounds 
were included i n t h i s i n v e s t i g a t i o n : cinnamic aldehyde and 
cinnamyl a l c o h o l , a c r y l i c acid e s t e r s , and α,β-unsaturated 
ni t r i l e s . 
For the unravel ing of the metabolic pathways of the respective 
unsaturated compounds the structure determination of mercapturic 
acids proved to be of essential importance. On the basis of the 
information provided by the st ructure of the excreted mercapturic 
acids conclusion can be drawn wi th respect to the b i o t r a n s ­
formation of the respective o l e f i n i c compounds, the stereochemical 
- 1 3 -
features of the glutathione conjugation and the stereoselectivity 
of the substrate towards the glutathione S-transferases. 
Experimental methodology 
The following scheme was elaborated for the study of the metabolic 
fate of the substrates investigated. 
After administration of potential alkylating agents to rats the 
amount of thioether in the urine is determined by the thioether 
test . This test is based on a hydrolytic cleavage of the 
thioether bond, resulting in the liberation of a free thiol group. 
The presence of the thiol group is determined by applying the 
reaction with 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB). The 
18 use of this reagent was f i r s t described by Ellman , therefore 
i t is commonly called Ellmans' reagent. The determination is 
based on the cleavage of the S-S bond of DTNB by the liberated 
thiol group, producing the yellow coloured anion of 5-thio-2-
nitrobenzoic acid, which can be spectrophotometrically measured 
at a wave-length at 412 nm. 
In case of an increase of the thioether excretion compared with a 
blanc experiment, the isolation of the mercapturic acids is 
undertaken. The mercapturic acids which theoretically can be 
- 1 4 -
envisaged are then synthesized by unambiguous routes. Knowledge 
of the chemical and physical properties of the potential 
metabolites greatly facilitate the detection, isolation and the 
identification of mercapturic acids in the excreted urine. The 
authentically prepared materials are also used to determine the 
recovery value of the amount of thioethers and to establish the 
optimal test conditions. 
When the electrophilic component which causes an enhanced thio-
ether excretion has been identified and the interferences by 
other substances can be excluded, the experiment can be directed 
to a more specific determination of the thioether amount. In this 
study specific determination of the mercapturic acids has been 
performed by using thin layer chromatography (t.l.c), gas 
chromatography (g.l.c.) - sometimes combined with mass spectro-
metry (g.c.-m.s.) - and high pressure liquid chromatography 
(h.p.l.c). Structure determination was performed by means of 
mass spectrometry (m.s.) and proton nuclear magnetic resonance 
('H-n.m.r.). 
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2.1 INTRODUCTORY REMARKS 
Styrène (phenylethene, vinylbenzene) is recognized as an important 
industrial chemical. The main part of the world production of 
styrene is used in the fabrication of plastics and resins. 
Consequently, exposure to high concentrations of styrene is a 
problem particularly encountered in factories engaged in its 
production or polymerization. However, it should be noted that 
styrene has been detected,albeit in low concentrations,in 
cigarette smoke , in ambient air, in rivers, and in drinking 
water in industrial regions where styrene is being produced or 
2 
processed. 
In industry there is a r i sk of being exposed to styrene during 
the production o f the monomeric ma te r i a l , during the polystyrene 
f ab r i ca t i on , whi le transport ing or handling l i q u i d s tyrene, whi le 
using latex paints or polyester putty and also during thermal 
decomposition o f styrene based p l a s t i c s . 
Exposure to styrene can occur by inha la t ion and d i rec t skin 
contact. I t is of i n te res t to mention that the uptake of styrene 
3 
in to blood increases under physiological s t ress . Respiratory 
protect ive devices are the most e f f ec t i ve means fo r reducing 
4 
styrene absorption by inha la t ion . There are c o n f l i c t i n g reports 
wi th regard to the s igni f icance and r e l a t i ve absorption through 
5-9 the skin in the development of t o x i c i t y . Even i f absorption 
through the sk in would be l i m i t e d , sk in protect ion i s necessary 
because of the r i sk of contact dermat i t i s . 
Occupational exposure to styrene has been reported to r esu l t 
i n a number of health problems, (amongst others) central nervous 
depression, mucous membrane i r r i t a t i o n , hematologic abnormal i t ies, 
resp i ra tory symptomatology, dermat i t is and reproductive and 
mutagenic t o x i c i t y . 
Short-term studies showed that styrene had mutagenic e f fec ts 
11-14 
a f te r metabolic ac t i va t i on , resu l t ing in styrene oxide , but 
15-18 there are also some negative resu l t s . I t is possible that 
these c o n f l i c t i n g resul ts wi th styrene are due to d i f f e ren t 
a c t i v i t i e s of the metabolizing system used. An a l te rna t i ve 
- 1 9 -
metabolic pathway proposing the areneoxide, styrene-3, 4-oxide, 
19 
as the mutagenic metabolite has also been advanced. 
Styrene ox ide, the common main metabolite of s t y r e n e , i s mutagenic 
i n b a c t e r i a , ^ 1 3 ' 1 5 - 1 8 · 2 0 - 2 2 yeasts l , d r o s o f i l a 23> 2 4 
chinese hamster c e l l s ' and human lymphocytes. 
I n d u s t r i a l workers who are exposed to styrene i n chemical plants 
processing styrene-polyester resins have an increased frequency 
of chromosomal aberratione i n the lymphocytes from peripheral 
24 blood. Chromosome breakage has been induced by styrene i n 
human lymphocytes in vitro and in a l l ium root t i p c e l l s in 
28 
г о. 
The metabolism of styrene has been the subject of many studies. 
The primary step of the major pathway in the metabolism of styrene 
29 30 31 ( I ) is the formation of styrene oxide ( I I ) ' ' , which is 
29 
subsequently hydrated to phenyl ethane-1, 2-diol ( V I I ) , or 
32-36 
conjugated wi th g l u t a t h i o n e . 
Phenyl ethane-1, 2-diol ( V I I ) can e i t h e r be conjugated w i t h 
31 37 glucuronic acid ' or be converted to mandelic acid ( X I ) , 
which i n turn is oxidized to phenylglyoxyl ic acid (X I I ) or benzoic 
acid ( X I I I ) . The l a t t e r i s conjugated with glycine to give 
31 37 40 hippur ic acid (XIV). ' ' A small amount o f styrene is 
metabolized to p-hydroxy-styrene ( V I I I ) , 1-phenyl-ethanol (IX) 
42 
and 2-phenyl-ethanol (X). (See also f i g u r e 1.) 
There is a good c o r r e l a t i o n between the content of styrene i n the 
ambient a i r and the concentrat ion of mandelic acid subsequently 
found i n u r i n e . The sum of the concentration of mandelic acid and 
phenylglyoxyl ic acid i n the 'morning a f t e r ' ur ine has recent ly 
42 been proposed as a measure of the exposure to styrene i n man. 
Hippuric acid is considered to be r e l a t i v e l y i n s e n s i t i v e as an 
43 index of styrene exposure i n human subjects. One of the 
reasons why h ippur ic acid f a i l s to be a r e l i a b l e exposure 
i n d i c a t o r may be the high non-exposure level (compared wi th the 
increment due to exposure) as well as a wide range of 
physiological v a r i a t i o n . Retarded urinary excret ion of h ippur ic 
- 2 0 -
acid forms another disadvantage of this metabolite as an exposure 
index. 
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2.2 IDENTIFICATION OF THREE SULPHUR-CONTAINING URINARY 
METABOLITES OF STYRENE IN THE RAT 
2.2.1 INTRODUCTION 
James & White were the f i r s t to show a mercapturic acid to be 
present in the urine of rats given styrene or styrene oxide; this 
compound appeared chromatographically to be identical with 
N-acetyl-S-(2-phenyl-2-hydroxyethyl)-cysteine (IV). They also 
found traces of another metabolite containing bivalent sulphur. 
Based on their chromatographic data, they identif ied this 
compound as N-acetyl-S-(2-phenyl ethyl)-cysteine (VI). 
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Scheme 1 Structures of the proposed mercapturic acids of styrene 
Since the epoxide ring of styrene oxide can be opened in two 
different ways, the question arises whether nucleophilic attack 
by glutathione in vivo can also take place at two positions (see 
scheme 1), eventually leading to the mercapturic acids III and 
IV, respectively. Therefore, the occurrence of different sulphur-
containing metabolites in urine of the rat after styrene 
administration was reinvestigated. 
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2.2.2 MATERIALS AND METHODS 
CHEMICALS 
Styrène, styrène oxide, triethylamine and sodium borohydride were 
purchased from Baker Chemicals N.V. (Netherlands). 
N-Acetylcysteine, 2-bromoacetophenone, silica gel 60 (70-230 mesh) 
and glass t.l.c. plates coated with silica gel pF2s4 were 
purchased from Merck A.G. (Germany). m-Chloroperbenzoic acid was 
obtained from Janssen Pharmaceutica N.V. (Belgium). Diazomethane 
2 
was prepared according to Moore and Reed. 
Dicyclohexylamine and phenetyl bromide were obtained from 
Fluka A.G. (Switzerland). 
ANIMALS 
Adult female Wistar rats (+ 200 g, about 6 weeks old), TNO-stock, 
Zeist (Netherlands) were used. The animals were housed in 
individual stainless steel metabolism cages, with free access to 
water and food (Hope Farms). Urine samples were collected daily in 
containers, pooled and frozen immediately until required for 
analysis. 
Styrene (250 mg/kg = 2.4 mmol/kg) in sesame oil was 
administered intraperitoneally daily for 3 weeks, except at 
weekends, unless otherwise mentioned. Controls were Injected with 
the oil only. 
THIN-LAYER CHROMATOGRAPHY 
Cbromatograms on t.l.c. glass plates (20 χ 20 cm) coated with a 
0.25 nun layer of silica gel pF
oc
.. were developed sequentially in 
the same direction with (a) hexane-diethyl ether (1:2, v/v); (b) 
methanol-diethyl ether (3:97, v/v) and (c) diethyl ether; 0.5 mm 
plates were used for preparative chromatography with the same 
eluents. After development of the plates, the spots were detected 
under u.v. light or by spraying with the reagent of Knight and 
3 
Young . 
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SPECTRA 
Infra-red spectra were obtained in soin. (CHC1 ) in a Perkin-
Elmer 257 spectrophotometer. 
Mass spectra were obtained with a V.G. Micromass 70-70 F mass 
о 
spectrometer at 160 ion source temp, and 70 eV. The materials 
о 
were introduced by direct probe insertion at 40 . Ion source 
-4 
pressure: 1.3 χ 10 Pa. 
Nuclear magnetic resonance spectra were obtained with 
compounds dissolved in CDC1 , using a 90 MHz Bruker LH 90 n.m.r. 
spectrometer, and tetramethylsilane as an internal reference 
(6 = 0.00 p.p.m.). 
SYNTHESES OF REFERENCE COMPOUNDS 
N-Acetyl-S-(l-phenyl-2-hydroxyethyl)cysteine methyl ester (methyl 
ester of III): 
(a) A mixture of 240 mg of styrene oxide (II), 350 mg of 
N-acetylcysteine and 200 mg of NaHCO was stirred in 20 ml of 
methanol at room temp, for 2 weeks. The progress of the reaction 
was followed by means of t.l.c. The reaction mixture was diluted 
with water and adjusted to pH 8, and washed with diethyl ether. 
After acidification to pH 1 with 2 M HCl and saturation with 
NaCl, the organic material was extracted with 6 χ 100 ml of 
chloroform. The chloroform extracts were dried (MgSO ), 
evaporated to dryness, the residue dissolved in methanol and 
treated with excess diazomethane in diethyl ether. The solvents 
were removed vn vacuo. After addition of water, the product was 
extracted with diethyl ether. After drying and removal of the 
solvent, 170 mg of an oily product remained, which on t.l.c, as 
described above, gave 105 mg of the methyl ester of III and 20 mg 
of the methyl ester of IV. 
(b) Compounds III and IV were also prepared according to 
James and White. Only compound IV could be isolated as its 
dicyclohexylammoniuffl salt. After careful acidification the 
reaction mixture was treated with ethereal diazomethane leading 
to the methyl esters of both III and IV which could be separated 
by preparative t.l.c. as described above. 
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N-Acetyl-S-(2-phenyl-2-hydroxyethyl)eysteine methyl ester (methyl· 
ester of IV): 
N-acetyl-S-phenacylcysteine (V) (1.4 g) was dissolved In 20 
ml of methanol. During 30 min 0.7 g of NaBH was added to the 
cooled and stirred soin. After an additional stirring for 30 min 
and heating at 45 , the soin, was cooled, 2 ml of water were 
added and the soin, was acidified to pH 1 with 2 M HCl and heated 
until the evolution of gas had ceased. The soin, was cone, to 5 
ml, filtered and evaporated to dryness in vacuo. Excess 
diazomethane in diethyl ether was added to the residue at 0 . The 
soin, was evaporated to dryness, the organic material dissolved 
in diethyl ether and the soin, washed with a saturated NaCl soin. 
After drying (MgSO or CaSO ) and evaporating the solvent, 1.1 g 
of crude product was obtained. Column chromatography (90 g of 
silica gel) with diethyl ether as eluent yielded 44 % of the 
methyl ester of IV. 
N-Acetyl-S-phenaoylcysteine methyl ester (methyl ester of V): 
N-Acetyl-S-phenacylcysteine (V) was prepared according to 
Jones and Hysert. Its methyl ester was obtained by reaction of 
the acid with diazomethane in diethyl ether and subsequent 
preparative t.l.c. (silica gel, eluent diethyl ether). After 
recrystallization from methanol-diethyl ether, a pale yellow 
solid (m.p. 83.5-85.5 ) was obtained in a yield of 60 %. 
ISOLATION OF THE METABOLITES FROM URINE 
Rat urine (750 ml) was acidified to pH 2 with 10 M HCl and 
extracted four times with 500 ml portions of ethyl acetate 
chloroform (2:3, v/v). The organic layers were separated by 
centrifugation at 2000 r.p.m. The combined layers were 
concentrated to 150 ml and then treated with excess diazomethane 
in ether. After washing twice with NaCl soin, and drying with 
CaSO , the solvent was removed in vacuo. From the remaining brown 
oil (800 mg), non-polar substances were removed by column 
chromatography (40 g silica gel) with ether as eluent. The 
material retained on the column was eluted with 250 ml of 2-
propanol. After evaporation of the 2-propanol, 170 mg of oil 
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remained that was chromatographed on four t.l.c. plates (0.5 mm 
silica gel) with hexane-diethyl ether (1:2 ν/ν), 3 % methanol in 
diethyl ether and diethyl ether as eluents. The fractions, 
corresponding with the R values of the authentic compounds were 
removed by scraping off, extraction with 2-propanol and 
evaporation of the solvent. The i.r., n.m.r. and mass spectra of 
the resulting light yellow oils, as well as their R values were 
in correspondence with those of the synthetic methyl esters of 
III, IV and V, respectively. 
DETERMINATION OF THE MOLAR RATIO OF THE MERCAPTURIC ACIDS III, IV 
AND V 
To determine the molar ratio of the acids III, IV and V, part of 
the urine extract obtained as mentioned above, was treated with 
diazomethane and after evaporation to dryness, separated by t.l.c. 
The fractions, in 5 cm bands, corresponding with the R values as 
F 
described earlier of the synthesized reference compounds were cut 
out. To the material obtained, 2 ml of water and 0.5 ml of 5 M 
NaOH were added. Then the reaction mixtures heated for 2 h at 
95-Θ7 , cooled, neutralized with 0.5 ml 5 M HCl and centrifugea. 
In the supernatants the SH-equivalents were determined according 
4 
to Eliman. These values furnished the molar ratio of III:IV:V. 
An extract of the urine of the control group, subjected to the 
same procedure, served as a blank. 
DETERMINATION OF TOTAL MERCAPTURIC ACID EXCRETION IN URINE 
Rats were treated with a single dose of styrene. 24 h urines were 
collected during three days and diluted with water to a standard 
vol. Mercapturic acids in the urine were determined according to 
Seutter-Berlage et al. with the following modification: 3 ml 
samples of the diluted urine were acidified to pH 2 with 10 M 
HCl, 6 ml of a mixture of ethyl acetate-chloroform (2:3, v/v) was 
added and the mixture shaken for 20 min. The organic layer were 
separated by centrifugation at 2500 r.p.m., and 4 ml were pipetted 
into a brown glass tube and evaporated to dryness under N . The 
residue was mixed with 2 ml of water and 0.5 ml of 5 M NaOH, 
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sealed under N„ and heated at 95-97 for 2 b. After cooling in 
ice, the soin, was neutralized with 0.5 ml of 5 M HCl. 
Subsequently, the free SH-groups were determined by the method of 
4 
Ellman. Urine samples of the control group served as blanks. 
Standard series of synthesized reference compounds added to urine 
samples and subjected to the same procedure, gave a recovery for 
compound III of 53.3 + 2.3, for IV of 56.7 + 0.6 and for V of 
65.1 + 1.7 % (each value % +_ S.D. (n=5)) recovery. The results 
have been corrected for these recovery values. 
2.2.3 RESULTS 
The methyl esters of a l l three isolated substances appeared 
chromatographically to be identical with those of the reference 
compounds (methyl esters of I I I , IV and V). I t was established 
that these materials partly decomposed under the condition of the 
gaschromatography (3 % OV 17, 190oC). Therefore isolation of the 
urinary metabolites was performed mainly by t . l . c . The Rp values 
for the methyl esters of I I I , IV and V, using the t . l . c . 
conditions mentioned above,were found to be 0.28, 0.39 and 0.45 
respectively. The i . r . spectra of the methyl esters of metabolites 
H I , IV and V were identical with those of the methyl esters of 
the authentic materials. The mass spectra of the methyl esters of 
the isolated and synthetic metabolites were also identical and 
pictured in figure 2. In addition to being identical with those 
of the synthetic material, the n.m.r. spectra showed that the 
methyl esters of I I I and IV (both from the urinary and the 
synthetic compounds) occurred as a mixture of two diastereoisomers 
as a consequence of the presence of a second chi ral centre at the 
benzylic carbon atom in addition to the α-carbon atom of the 
cysteine moiety (exclusively in the R-configuration). The ratios 
of the amounts of the isomers in urinary metabolite I I I (see 
table 1, footnote 2) were estimated by integration of the n.m.r. 
signals and showed that one of the isomers was present in three 
times the amount of the other. The rat io of the isomers of urinary 
compound IV could not be estimated by integration. The n.m.r. data 
are summarized in table 1. 
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To estimate the molar ratio of the acids III:IV:V, the analyses 
were performed in duplicate. The mean result amounted to 65:34:1. 
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Figure 2 Mass spectra of the metabolites III (A), IV (B) and V (C) 
After a single administration of styrene (2.4 mmol/kg), on the 
first day 10.4 + 1.1 % of the dose was excreted as mercapturic 
acids and on the second day 0.26 + 0.12 %. On the third day the 
mercapturic acid excretion was no higher than that of the blanks. 
The total excretion amounted to 10.7 + 1.0 % (+ S.D. (n=5)). 
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TABLE 1 'H-n.m.r. data of the reference compounds 
ι 
Assignment 
СОСН 
ОН 
С
С
Н CHOHCHS 
D O Δ 
SCH„CH 
2 
соосн3 
с
в
н5снсн2он 
c6H5cocH2s 
C^H^CHOHCH^SCH, 
6 о — ¿ 
SCH„CH 
2 
NH 
с£ь 
г^ 
Methyl ester of III 
(p.p.m.) 
1.92(s) and 2.04(s) 
1.9-2.6(br)3 
2.86-2.97(m) 
2 
3.71(s) and 3.76(s) 
3.8-4.2(m) 
4.69-4.96(m) 
6.22(d) and 6.46(d)2 
7.32(s) and 7.33(s)2 
Methyl ester of IV 
(p.p.m.) 
2.04(s) 
2.5-3.2(br)3 
2.77-2.93(m) 
3.02(d)4 
3.76(s) and 3.77(s) 
4.67-5.08(m) 
6.53-6.74(2d)2 
7.34(s) 
Methyl ester of V 
(p.p.m.) 
2.04(s) 
3.05(d)5 
3.72(s) 
3.90(s) and 3.91(s) 
4.76-4.96(m) 
6.66(d) 
7.33-7.66(m)6 
7.91-8.01(m)7 
Abbreviations: (s) singlet, (d) doublet, (m) multiplet, (br) broad 
1 4 
in CDC1 , internal reference: TMS δ 0.00 p.p.m. J 5.5 Hz 
2 5 
2 diastereöisomers J 5.3 Hz 
η 6 
exchanges with D O meta and para protons 
2
 7 
ortho protons 
Integration of the signals correspond with the number of underlined protons 
2.2.4 DISCUSSION 
The simultaneous occurrence of metabolites I I I and IV in the 
urine of rats that were treated with styrene form a clear 
indication that the metabolism in vivo of styrene takes place 
through the intermediacy of styrene oxide. The metabolites I I I 
and IV can only be explained to arise by metabolic attack at the 
a- and ß-position of styrene oxide. Our results here confirm 
earlier reports ' of metabolism of styrene through i ts 
epoxide. 
One of the metabolites, viz. IV, agrees with that postulated 
g 
by James and Jeffery , it has the same chromatographic 
characteristics. In contrast to compound IV, product III could 
not be isolated as its dicyclohexylammoni um salt, neither during 
the authentic preparation according to James and White , nor 
from the urine extracts. This might explain why compound III has 
not been recognized earlier as a metabolite of styrene. It should 
be noted that James and White mention an unidentified metabolic 
product containing bivalent sulfur, present in smaller amounts 
than compound IV. Although these authors attribute structure VI 
to this metabolite, comparison of our and their chromatographic 
data rather suggests structure V. This S-phenacyl cysteine 
derivative may arise from compound IV by metabolic oxidation. 
That this metabolite was not formed as an artefact during the 
isolation procedure from urine was ascertained by subjecting a 
pure sample of methyl ester of IV to the same purification 
procedure; no methyl ester of V was formed. Hence, compound V 
must be considered as another metabolite of styrene in the rat. 
It is of interest to note that at least in metabolite III, 
there is a clear enzymic preference for one of the 
diastereoisomers (ratio 3:1). This aspect is discussed further in 
the next chapter. In the literature the direct addition of 
glutathione to unsaturated compounds by glutathione S-alkene-
9-12 transferase has been reported. In this way, the S-phenyl-
ethyl derivative VI may be expected as an additional metabolite. 
Therefore this substance was also synthesized. 
However, under our conditions this compound was not detected in 
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Figure 3 Structures of the urinary mercapturic acids of styrene 
urine from rats treated with styrene. James and White claim to 
have found traces of this material. However, as mentioned above, 
structure V may be more likely for the bivalent sulfur 
containing metabolite isolated by these authors. 
Our in vivo results are in agreement with the in vitro 
experiments. Styrene oxide was incubated with glutathione in the 
presence of rat liver cytosolic fraction. Two conjugates were 
formed. Spectral analysis (m.s., i.r. and 'H-n.m.r.) revealed the 
presence of two isomers namely S-(l-phenyl-2-hydroxy-ethyl) 
glutathione and S-(2-phenyl-2-hydroxy-ethyl) glutathione. These 
materials can be seen as precursors of the main metabolites III 
and IV, respectively. 
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2.3 STEREOSELECTIVE OXIDATION OF STÏRENE TO R-(+)-STYRENE OXIDE 
IN RAT 
2.3.1 INTRODUCTION 
In the previous chapter i t has been mentioned that the formation 
of styrene oxide is the principal f i r s t step in the biotrans-
formation of styrene. This intermediate can be further metabolized 
1 2 by microsomal epoxide hydrolase to 1-phenylethane-1,2-diol * 
and by the glutathione S-transferases to several glutathione 
3 4 conjugates, giving ultimately mercapturic acids ' , which are 
excreted in urine. Theoretically two optical isomers of styrene 
oxide can be formed (figure 4). From the opt ical ly active styrene 
epoxides in turn opt ical ly active diols and glutathione conjugates 
can be expected (figure 4). 
.CH=CH2 
Г il 
[oj 
epoxide 
hydrolase 
O H 
C H - C H ô O H 
glutathione 
S-1ransferase 
ÇH-CHjSe 
Ш 
IV " 
Figure 4 Formation of optically active diols and glutathione conjugates 
from styrene via the optical isomers of styrene oxide 
Previous results showed that some form of stereoselectivity occurs 
during the biotransformation of styrene to mercapturic acids, 
based on the ratio of the diastereoisomers isolated. (Compound III 
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in scheme 1, chapter 2.2., see also ref. 4.) This observation may 
be explained in two ways: 
a. the oxidation of styrene to styrene oxide is stereoselective; 
b. either the glutathione S-transferase or the epoxide hydrolase 
or both have a preference for one of the enantiomers of styrene 
oxide. I t is known that microsomal epoxide hydrolase shows no 
5 fi 
signif icant stereoselectivity towards styrene oxide. ' By 
administration of optically pure styrene oxide and racemic 
styrene oxide we aim to elucidate which of the theoretical 
possibi l i t ies cause the observed diastereoisomeric rat io of the 
hydroxy mercapturic acids from styrene (related to the conjugates 
H I ' and IV') in urine of rats. The diastereoisomeric rat io of 
the hydroxy mercapturic acid was determined by HPLC. 
2.3.2 MATERIALS AND METHODS 
Information concerning the determination of the total thioether 
excretion, the isolation of the mercapturic acids, the 
determination of the molar ratio of the mercapturic acids III and 
IV is given in chapter 2.2.2. 
CHEMICALS 
Styrene and racemic styrene oxide were purchased from Baker 
Chemicals N.V. (The Netherlands). The optical isomers of styrene 
7 
oxide were synthesized according to Golding. Both isomers were 
24 о 24 о 
86 % optically pure. ( <* +25.4 (neat) and α - 26.1 
(neat)). The mercapturic acids were synthesised as described in 
chapter 2.2.2., and diastereoisomers were separated by HPLC 
ivide infra). 
ANIMALS 
The rats were treated intraperitoneally with a single dose of 
styrene (250 mg/kg) or styrene oxide (150 mgAg, racemic or 
optically pure) dissolved in sesame oil. Controls were injected 
with the oil only. For isolation purposes, the compounds were 
administered daily for three weeks except at weekends. 
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CHROMATOGRAPHY 
High pressure liquid chromatography: a Waters Associates HPLC was 
used: Chromatography pump model M 6000a, an U 6K injector and an 
absorbance detector model 440 (254 nm.). Flow 1.5 ml/min., eluent 
CHC1 , column 15 cm χ 4.6 mm, packed with silica gel Lichrosorb 
60, 5μ, N=47000 plates/meter. 
DETERMINATION OF THE RATIO OF DIASTERE0IS0MERS OF COMPOUND III 
AND IV 
The metabolites III and IV, isolated by t.l.c, were dissolved in 
CHC1-, and analysed by HPLC. The ratio of the diastereoisomers was 
determined by integrating the peak area of the isomers. The 
retention times of the diastereoisomers of compound III were 15.7 
and 17.6 min. and of the diastereoisomers of compound IV were 10.6 
and 11.5 min, respectively. 
2.3.3 RESULTS 
Mercapturic acids were isolated from urine and ident i f ied as their 
methyl esters with n.m.r. as previously described in chapter 
2.2.3. In table 2 the percentage of the dose excreted as 
mercapturic acid as well as the ratio of the most abundant 
mercapturic acids I I I , N-acetyl-S-(l-phenyl-2-hydroxy-ethyl) 
cysteine, and IV, N-acetyl-S-(2-phenyl-2-hydroxy-ethyl)cysteine, 
as determined in the urine of rats after administration of 
styrene and styrene oxide (optically pure or racemic), are given. 
All mercapturic acids were excreted within 24 hrs. The observed 
preference of the formation of I I I in comparison to IV shows a 
clear regioselective behaviour of glutathione transferase towards 
styrene oxide, optical ly pure or racemic. 
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TABLE 2 
Total thloether excretion In % of the dose, 150 mgAg, n=4, and 
the molar ratio of the mercapturlc acids III and IV, after 
administration of styrene and styrene oxide. (Optically pure or 
racemic). 
Compound % of dose ratio III : IV 
гас. styrene oxide 25.5 +_ 3.1 63 : 37 
(+)-R- styrene oxide 23.2 + 2.9 71 : 29 
(-)-S- styrene oxide 28.7 + 2.4 57 : 43 
styrene 10.7+1.0 65 : 35 
From the 'H-n.m.r. spectra i t could be deduced that compound III 
occured as a mixture of two diastereoisomers. Using HPLC i t was 
possible to determine the ratio of diastereoisomers for the 
methyl esters of both compound III and IV. There rat io ' s are 
given in table 3 . Both optically active epoxides yielded 
predominantly one diastereoisomer. From styrene i tself the 
diastereoisomers are formed in a ratio of 19:81 for ІПдіІІІц and 
18:82 for І дГІ ц. 
TABLE 3 
Ratio of diastereoisomers of mercapturic acid III and IV 
determined by HPLC*, after administration of styrene and styrene 
oxide.(Optically pure or racemic). 
Compound 
гас. styrene oxide 
(+)-R- styrene oxide 
(-)-S- styrene oxide 
styrene 
ratio III : 
52 : 48 
9 : 91 
86 : 14 
19 : 81 
1τι
Β 
ratio IV. : IV„ 
A В 
53 : 47 
20 : 80 
96 : 4 
18 : 82 
^t I I IA 1 5' 7 m l n , I I IB 1 7 · 6 m i n' I VA 1 0 · 6 ш і п · I VB 1 1 · 5 m i n 
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2.3.4 DISCUSSION 
Af te r adminis t rat ion o f styrène a ra t i o of diastereoisomers o f 
about 4 :1 was found f o r both compound I I I (N-acety l -S-( l -phenyl -2-
hydroxy-ethyl)cysteine) and compound IV (N-acetyl-S-(2-phenyl-2-
hydroxy-ethyl)cysteine) (Table 3 ) . This phenomenon can be 
explained in the fo l lowing ways (see f igure 5 ) : 
a) a stereoselect ive ox idat ion of styrene ( I ) to styrene oxide 
( 1 1 . and I l g ) by the mixed funct ion oxidase system, fol lowed by a 
s tereospeci f ic r ing opening of 11. and I I B , transformed by the 
g lutath ione transferases to H I « , IV« and I H D » IVn, respect ive ly ; 
b) formation o f equal amounts of styrene oxide ( I I ) , but a 
preference of the glutathione transferase f o r one of two epoxides 
in the biotransformation to I I I«> IV» respect ively Ш ц , IVn. 
(stereoselect ive conjugat ion). 
Administrat ion of o p t i c a l l y pure (85 %) S-(-)styrene oxide ( П д ) 
resul ted i n formation of over 85 % of one diastereoisomer ( Ш д 
and I V . ) , which implies t h a t the r ing opening by 
с
б Н 5 - . 
н< 
C - C H 5 
I I A ( S ) 
C6H5' 
.CH=CH2 
H. 
C e H s ^ 
"C-CHa 
I 1 B ( R ) 
ι
 2 
SR' 
I11A(R) I V A ( S ) IUB(S) 
C-CH^SR' 
I 2 
OH 
C-CHj-OH I 
SR' 
r
-[-CH2CH-NHCOCH3 COOH 
I 2 
OH 
IVe(R) 
Figure 5 Absolute configurations of the hydroxy-mercapturic 
acids III and IV 
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glutathione S-transferases occurs s t e r e o - s p e c i f i c . A s i m i l a r 
r e s u l t was obtained a f t e r administrat ion of R-(+)-styrene oxide 
( П о ) . The f a c t t h a t from each isomeric epoxide only one set of 
diastereoisomers I I I and IV is predominantly formed,is i n 
agreement w i t h the current idea about the mechanism of the enzyme 
catalyzed conjugation of g lutath ione, which involves an S.,2 attack 
8 9 
of the n u c l e o p h i l i c sulphur atom a t the e l e c t r o p h i l i c centre. ' 
An Sjgl type r e a c t i o n , i n which the enzyme act ivates the epoxide 
r i n g , r e s u l t i n g i n the formation of a carbenium i o n , would have 
resulted i n a mixture of diastereoisomers. This excludes a 
stereoselect ive ox idat ion of styrene to i t s oxide i n combination 
wi th a racemization during the r i n g opening process of the 
epoxide. The observed r e g i o s e l e c t i v i t y (i.e. the r a t i o of I I I . 
versus IV. and I I I Q versus IVn respect ive ly) is the opposite of the 
one obtained s y n t h e t i c a l l y under basic condit ions (3:17, I I I : I V ) 
suggesting t h a t some form of acid c a t a l y s i s by the enzyme occurs. 
Administrat ion of the racemic mixture of styrene oxide gave only a 
s l i g h t excess o f I I I . above I I I B , and also of IV. above IVn. 
Excluding the p o s s i b i l i t y of racemization, these r e s u l t s suggest a 
small enzymatic s t e r e o s e l e c t i v i t y of the glutathione transferases 
toward racemic styrene oxide. The s l i g h t l y higher t h i o e t h e r 
excret ion a f t e r administrat ion of S-(-)-styrene oxide i n 
comparison to the R-(+)-isomer suggests t h a t the S-(-)-isonier is 
the bet ter substrate. * 
From гп гіго experiments the following results have been 
obtained. The apparent Michaelis-Menten parameters of the rat 
liver glutathione transferases for the conjugation of R-(+)-
styrene oxide and S-(-)-styrene oxide appeared to be: 
К v
m 
R-(+)-styrene oxide 0.99 ï 0.13 mM 116 +i4 nmol/min/mg protein 
S-(-)-styrene oxide 0.54 +• 0.03 mM 160 + 11 nmol/min/mg protein 
This finding supports the suggestion that the S-(-)enantiomer is 
the better substrate. 
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The stereospecific ring opening of styrene oxide by glutathione 
S-transferases and the s l ight preference of the transferases for 
one of the optical isomers, exclude the possibi l i ty b, mentioned 
above. In conclusion, i t is clear that the observed ratio of 1:4 
of the diastereoisomers of the mercapturic acids I I I and IV 
formed from styrene reflects the ratio of optical isomers of 
styrene oxide. This leads to the conclusion that the oxidation of 
styrene by the microsomal mixed function oxidases of the rat 
occurs stereoselective with a considerable degree of preference 
for the R-(+)-isonier (see figure 5 ) . i t should be noticed that 
this preferre (R)-oxide is a lesser substrate in conjugation with 
glutathione than the S-enantiomer. Stereoselective formation of 
opt ical ly active metabolites during biotransformation can have 
important consequences for the biological a c t i v i t y , such as 
mutagenicity and carcinogenicity, as has been demonstrated for 
benzo(a) pyrene. ' Interestingly the R-(+)-isomer is less 
mutagenic than i t s enantiomer towards Salmonella typhimurium TA 
100. Thus the metabolic pathway of styrene proceeds preferentially 
through the least mutagenic styrene oxide enantiomer. 
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2.4 THE INTRAMOLECULAR REARRANGEMENT OF STYRENE OXIDE FORMED AS 
AN INTERMEDIATE IN THE BIOTRANSFORMATION OF STYRENE 
2.4.1 INTRODUCTION 
During our work on styrene metabolism , we i s o l a t e d a substance 
t h a t on the basis of spectral data was characterized as the 
glycine conjugate of phenyl aceti с acid (phenaceturic acid ( X V I I ) ) . 
This a c i d , however, has been reported not to be a metabolite of 
styrene. We were i n c l i n e d to doubt the non-existence of t h i s 
metabolite of styrene, since the minor metabolite 2-phenylethanol 
3 4 5 
(X) can be eas i ly oxidized to phenylacetic acid (XVI). ' I t 
has been shown t h a t phenylacetic acid is completely conjugated 
w i t h g lycine to give phenaceturic acid (XVI). In order to 
provide evidence f o r t h i s explanation of the occurrence of 
phenaceturic acid and to exclude interference from n a t u r a l l y 
occurr ing phenaceturic a c i d , experiments were conducted with 
labeled styrene, viz. dn-styrene. The deuterated styrene 
experiments could also give decisive informat ion about the 
f o l l o w i n g second possible metabolic pathway i n the b i o t r a n s ­
formation of styrene ( I ) i n t o phenaceturic acid (XVI I ) : 
rearrangement of styrene oxide ( I I ) may lead to phenylacetaldehyde 
О 
C6HS-CH=CH2 • C6H5-CH-CH2 
I 
} 
C6H5-CH2CH2OH • СбН5-СН2-<° • СвНб-СНг-СООН 
Χ ΣΖ 
GLYCINE 
ТУТ 
о Η 
C6H5-CH2-C-N-CH2-COOH 
Figure 6 Fonnation of Ν-(phenylacetyl)glycine (XVII) 
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(XV) that on subsequent oxidation to phenylacetic acid (XVI) and 
conjugation with glycine would result in the formation of 
phenaceturic acid (XVII). 
2.4.2 MATERIALS AND METHODS 
CHEMICALS 
Styrene and styrene oxide were purchased from Baker Chemicals N.V. 
(The Netherlands), d -Styrene (98 atom % D), N-(phenylacetyl) 
о 
glycine (phenaceturic acid), and m-chloroperbenzoic acid were 
obtained from Janssen Pharmaceutica N.V. (Belgium). d -Styrene 
о 
oxide was prepared by oxidation of d„-styrene according to 
7 8 
Vogel. Neither dft-styrene nor d„-styrene oxide showed any 
chemical impurity by g.l.c. and 'H-n.m.r. As a reference, the 
methyl ester of phenaceturic acid was prepared by treatment of 
the acid with diazomethane in diethyl ether (colourless crystals, 
m.p. 82-840C). Information concerning the animal treatment, 
preparative chromatography, spectra measurement and isolation 
procedures is given in chapter 2.2.2. 
GAS CHROMATOGRAPHY 
A Hewlett-Packard 5710 gas Chromatograph equipped with a clean 
glass injection port and a glass column of 1.8 m length, 3 mm int. 
diam. containing 2 % OV-101 on gaschrom Q 80-100 mesh, was used 
with an ATID, under the following conditions: injection block 
210 C, column 180 C, detector 240 C, He carrier flow 30 ml/min. 
PREPARATION OF SAMPLES FOR G.L.C. ANALYSIS 
A 24-hour urine was diluted to 25 ml, 3 ml of which were extracted 
with б ml of CHC1 . After centrifugation at 2000 r.p.m. during 10 
min, 4 ml of the organic layer was treated with diazomethane in 
ether. Then the solution was evaporated to dryness at 40oC, and 
dissolved in 1 ml of methanol. This solution (1 μΐ) was Injected 
into the column. Hexobarbital was used as an internal standard. 
R for hippuric acid was 1.81 min, phenaceturic acid 2.39 min, 
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hexobarbital 3.62 min; there was a linear relationship between 
phenaceturic acid cone, and peak area in the range 1-20 ymol. 
2.4.3 RESULTS 
Styrene 
After administration of styrene to rats, phenaceturic acid was 
isolated from urine and identified as its methyl ester. The 
structure of the substance was confirmed by 'H-n.m.r. 
spectroscopy. ('H-n.m.r. (CDC13): δ 3.64 (s, 2H, CgHgCl·^), δ 3.72 
(s, ЗН, 0СН 3), δ 4.01 (d, 2Н, NHCH2), δ 5.88-6.16 (m, ΝΗ), δ 7.33 
(s, 5Η, Cz-Hj-).) In addition the chromatographic data (Rp0.33, 
R.2.39 min), melting point (82-840C) and i.r. spectrum 
-1 -1 
( V N M 3 4 3 0 cm , V C 01740, 1665 cm ) were identical with those of 
the reference compound. Mass spectra of the isolated and reference 
substance were also identical and the most prominent peaks are 
given in table 4 (methyl ester of compound XVII). Quantitative 
results were obtained by g.l.c. After administration of a single 
dose of styrene (150 mg/kg = 1.44 tmol/kg) a total excretion of 
7.25 + 1.75 ymol/24 h urine (n=5) of phenaceturic acid was 
measured. The excretion of the control group amounted to 3.00 + 
0.75 wmol/24 h urine (n=8). This significantly increased excretion 
(P<0.0025) occurred in the first 24 h. Then the excretion returned 
to normal. From these data the contribution to the excretion of 
phenaceturic acid resulting from styrene amounted to 1.40 + 
0.06 % (n=5) of the dose. Continuous administration of styrene at 
the same dose (4 days) resulted in a mean excretion of 7.50 + 
0.50 wmol/24 h urine (n=5). 48 Hours after the last dose the 
excretion returned to a normal level. 
dg-Styrene 
After continuous administration (4 days) of dg-styrene (150 mg/kg 
=1.34 mmol/kg), a mixture of methyl esters of phenaceturic acid 
was isolated from urine. By means of mass spectrometry the 
structure of the substances was established (table 4 ) . The molar 
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ratio of the respective d-labeled methyl phenaceturates was 
determined by means of the peak height of the four main fragments 
in the mass spectra. The molar ratio appeared to be Х ІІ:Х ГІІ: 
XIX:XX = 100:33:42:47 (the average of four spectra, S.D. < 2 %). 
Using this ratio the signal areas in the 'H-n.m.r. in the mixture 
of d-labeled esters can be deduced. The predicted and observed 
values were consistent. The unlabeled compound XVII is the methyl 
ester of endogenously occurring phenaceturic acid and amounted to 
45 % of the totally excreted mixture of methyl esters of 
phenaceturic acid. 
TABLE 4 Mass spectra of the methyl esters of the isolated 
phenaceturic acids. 
XVII' XVIII XIX XX 
M 
-осн3 
-COOCH 
-NH -CH -COOCH 
2 2 іі 
-
C6 H5- C H2 
-
C6 D5- C D2 
-СЛ> -CDH 
Ό 5 
-C„D -CH„ 6 5 2 
-CO-NH-CH -COOCH 
-
C 6 H 5 -
C H 2 - C O 
-
с
б
 с С 0 
-C-D -CDH-CO 
о э 
-C„D -CH -CO 
6 5 2 
207 
176 
148 
118 
212 
181 
153 
123 
213 
182 
154 
124 
214 
183 
155 
125 
116 
91 
88 
116 
96 
88 
116 
97 
88 
116 
98 
88 
XVI I' 
XVIII 
XIX 
XX 
C,.H-CH -CO-NH-CH -COOCH., 6 5 2 2 3 
C,,D-CH -CO-NH-CH -COOCH, 6 5 2 2 3 
C_D -CDH-CO-NH-CH -C00CH
o 6 5 2 3 
C^D -CD -CO-NH-CH -COOCH., 6 5 2 2 3 
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Styrène oxide 
Both s ing le adminis t rat ion o f styrene oxide (150 mg/kg = 1.25 
m o l / k g ) and continuous administrat ion (150 mg/kg = 1.25 mmol/kg/ 
day f o r 5 days) did not resu l t i n any s i g n i f i c a n t increase i n 
phenaceturic acid excret ion (4.00 + 0.75 уітю1/24 h urine (n=5)) as 
compared w i t h the control group. 
d „Styrene oxide 
о 
A f t e r continuous administrat ion of dg-styrene oxide (150 mg/kg = 
1.25 mmol/kg d a i l y , 5 days per week f o r 3 weeks), no deuterated 
phenaceturic acid could be iso lated or detected by mass 
spectroscopy. 
2.4.4 DISCUSSION 
A f t e r administrat ion of dg-styrene to the r a t a mixture of 
deuterated phenaceturic acids (XVI I I , XIX, XX) could be i s o l a t e d 
from the u r i n e . This shows, t h a t , in contrast t o the f indings of 
2 
El Masri e t al (1958) , phenaceturic acid is a metabolite o f 
s tyrene, indeed. 
I t s formation can be explained by e i t h e r o f two mechanisms. In 
the f i r s t (route ( a ) , f i g u r e 7 ) , styrene ( I ) reacts to form 
styrene oxide ( I I ) , a small part of which undergoes intramolecular 
rearrangement to phenylacetaldehyde (XV). The rearrangement of an 
epoxide to an aldehyde i s a well known r e a c t i o n ; such reactions 
have been shown to occur in vivo, f o r example i n the metabolism of 
8 9 
v iny l c h l o r i d e . ' In the second (route ( b ) , f i g u r e 7 ) , a 
d i r e c t water a d d i t i o n to styrene results i n the formation of the 
metabolites 1-phenylethanol (IX) and 2-phenylethanol (X). Both 
3 
compounds have been reported as metabolites of styrene. The 
formation of these metabolites from styrene oxide i s u n l i k e l y . 
Subsequently,2-phenylethanol i s oxidized to phenylacetaldehyde. 
Both routes (a) and (b) r e s u l t i n an intermediate formation of 
phenylacetaldehyde (XV) t h a t i s then oxidized to phenylacetic acid 
(XVI) and, a f t e r conjugation with g l y c i n e , is excreted i n the 
4-6 
ur ine as phenaceturic ac id (Х П ) . The i s o l a t i o n of 
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dy-phenaceturic acid ester (XX) after administration of d„-styrene 
can only be reconciled with a rearrangement of dg-styrene oxide 
to dg-phenylacetaldehyde as an intermediate step via route (a) , 
as the presence of two deuterons in the α-position in 
d^-phenaceturic acid cannot be accounted for in any other way. 
However, our experiments do not allow us to conclude which 
mechanism is prefered in the formation of dg-and dg-phenaceturic 
acids. Two explanations can be envisaged: ( i ) a deuteron in the 
methylene group of the compounds XV, XVI and XVII being very 
reactive, an easy exchange by a proton from the medium may take 
place in any of these compounds; ( i i ) in our experiments we 
started with a dg-styrene of 98 atom % D, so, that a s l ight 
contamination with CgDyH had to be expected. Both ( i ) and ( i i ) 
explain the isolation of dg-phenaceturic acid ester (XIX) and 
dg-phenaceturic acid ester (XVIII) independent of the route 
fol 1 owed. 
но-^~Л-сн=сн2 
1 Ш 
<^Л-СН=СН2 • 
^"VcHj-CHjOH 
χ 
•h 
^"Л-СНОН-СНз 
IX 
glutathione 
conjugates 
со-соон 
хп 
соон 
YÏÏI 
CO-NH-CHyCOOH 
УГС7 
Figure 7 Phenaceturic acid (XVII), a new metabolite of styrene 
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Systemically introduced styrène oxide ( I I ) is not metabolized to 
phenaceturic ac id ; even a f te r continuous dosing of dn-styrene 
oxide fo r 3 weeks, no deuterated phenaceturic acids could be 
detected nei ther by n.m.r. nor by mass spectrometry. This f ind ing 
is qu i te remarkable and unexpected. The reason f o r th i s apparent 
discrepancy is not c lear . I t may be suggested that e i the r the 
epoxidation of styrene to styrene oxide and the subsequent i n t r a -
molecular rearrangement o f a t least part o f the styrene oxide 
must take place almost simultaneously, or the s i tes at which the 
epoxidation and the rearrangement occur must be very close in a 
qu i te small compartment. I t is well known from epoxide 
rearrangement that they are par t i cu la r catalyzed by Lewis acids. 
In vivo coordinat ion o f the oxide, which is introduced along 
w i th the oxygen t rans fer to styrene, may well be responsible for 
the rearrangement to phenylacetaldehyde. Such coordinat ion may 
not be present i f styrene oxide is introduced as such. Our 
observation may represent addi t ional pharmacological evidence to 
g 
support the opinion of Bonse and Metzler , concerning the 
comparable metabolism of t r ich loroethy lene to c h l o r a l , that ' i n 
the organism a t the s i t e of formation of the epoxide an 
environment wi th the propert ies of an electron acceptor induces 
the rearrangement to the aldehyde'. I t has been reported in the 
l i t e r a t u r e that aldehydes can be formed as tox ic intermediates. 
The fac t that phenylacetaldehyde occurs as an intermediate 
product i n the metabolism of styrene uncovers a new p o s s i b i l i t y 
fo r the tox ic mechanism of t h i s compound. I t is known that the 
most common tox ic actions a f t e r exposure to styrene are i r r i t a t i o n 
of the s k i n , eyes and resp i ra tory t r ac t and depression of the 
11-12 
central nervous system. The possible ro le of phenylacetal-
dehyde as a tox ic intermediate product con t r ibu t ing to these 
phenomena deserves fu r the r a t ten t ion . 
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2 . 5 EXCLUSION OF THE INTERMEDIACY OF STYRENE OR STYRENE OXIDE IN 
THE MECHANISM OF FORMATION OF MERCAPTURIC ACIDS FROM 
(1-BROMOETHYL)BENZENE AND (2-BROMOETHYL)BENZENE IN THE RAT 
2.5.1 INTRODUCTION 
1-8 9-12 
Several a lky lha l i des , inc luding cycloalky lhal ides and 13-16 
ary l al kyl hal i des , are metabolized by rats and rabbits to 
alkylmercapturic acids. In some cases the formation of the 
corresponding hydroxyalkyl-mercapturic acids has also been 
8-12 15 17-19 
reported. ' * I t was t e n t a t i v e l y suggested by James 
g 
and J e f f e r y t h a t the hydroxyalkyl-mercapturic acids might be 
formed from the a lky lha l ides by one of two mechanisms. The f i r s t 
involves a displacement of the haloqen atom by g l u t a t h i o n e , 
20 
catalysed by glutathione S-alkyltransferase and subsequent 
hydroxy lat ion. The second proceeds by dehydrohalogenation, 
subsequent epoxidat ion, and conjugation of the epoxide wi th 
21 g l u t a t h i o n e , catalysed by glutathione 5-epoxidetransferase. In 
22 
a t h i r d mechanism which was proposed by Boyland and Chasseaud 
the carbon atom of the a l k y l h a l i de adjacent to the one bearing the 
halogen atom is f i r s t hydroxylated and then by dehydrohalogenation 
the epoxide w i l l be formed, a f t e r which conjugation of the epoxide 
w i t h glutathione occurs. The second and t h i r d hypotheses may be 
supported by the observation t h a t bromocyclohexane, cyclohexene, 
and 1,2-epoxycyclohexane a l l y ie lded the same m e t a b o l i t e , 
9-12 N-acetyl-S-(2-hydroxycyclohexyl)cystei ne. S imi1ar ly, 
phenylethyl bromide, styrene and styrene oxide also have a common 
m e t a b o l i t e , гг. N-acetyl-S-(2-phenyl-2-hydroxyethyl)cysteine 
( I V ) . This substance, however, is also a metabolite of phenyl-
15 
ethy lcyste ine , i n d i c a t i n g a mechanism not invo lv ing 
epoxidat ion, and favouring the f i r s t hypothesis. We i s o l a t e d and 
i d e n t i f i e d a second hydroxymercapturic a c i d , viz. N-acetyl-S-
( l-phenyl-2-hydroxyethyl)cysteine ( I I I ) , as a metabolite of 
styrene ( I ) and styrene oxide ( I I ) . The c h a r a c t e r i s t i c 
simultaneous occurrence of I I I and IV as metabolites of styrene 
oxide ( I I ) gives the p o s s i b i l i t y of obtaining more information 
concerning the mechanism of the metabolism of the a r y l a l k y l h a l i des 
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Figure 8 Formation of mercapturic acids from the aralkyl-
bromides XXI and XXII 
(1-bromoethyl)benzene (XXI) and (2-bromoethyl)benzene (XXII). We 
included both arylalkylbromi des in this study because both on 
dehalogenation will lead to styrene. For compound XXI even the 
dehalogenation may be easier than for XXII. Moreover having the 
halogen atom at two different positions, offers an additional 
possibility to differentiate between the first mechanism and the 
other two. 
2.5.2 MATERIALS AND METHODS 
CHEMICALS 
(1-Bromoethyl)benzene and (2-bromoethyl)benzene were obtained 
from К & К Labs, INC Pharmaceuticals, Inc. (Canada). 
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ANIMAL TREATMENT 
(1-Bromoethyl)benzene (150 mg/kg = 0.81 mmol/kg) and (2-
bromoethyl)benzene (150 mg/kg =0.81 mmol/kg) In sesame oil were 
administered intraperitoneally daily for 2 weeks, except at 
weekends, unless otherwise mentioned. Controls were injected with 
the oil only. 
SYNTHESES OF REFERENCE COMPOUNDS 
N-Acetyl-S-(l-phenyl-2-hydroxyethyl)cysteine methyl ester (methyl 
ester of III), N-acetyl-S-(2-phenyl-hydroxyethyl)cysteine methyl 
ester (methyl ester of IV) and N-acetyl-S-phenacylcysteine methyl 
ester (methyl ester of V), were prepared as described in chapter 
2.2.2. 
N-Aoetyl-S-2-phenylethylaysteine methyl ester (methyl ester of 
VI). (2-Bromoethyl)benzene (185 mg), 175 mg of N-acetylcysteine 
methyl ester and 100 mg of triethylamine, in the presence of a 
catalytic amount of KI were kept overnight at 100 in 20 ml of 
dimethylsulphoxide. After mixing with ice and extraction with 
diethyl ether, the dried extract (MgSO ) was subjected to t.l.c. 
о (silica gel, eluent diethyl ether); yield 76 %, m.p. 75-76.5 . 
N-Acetyl-S-l-phenylethyloysteine methyl ester (methyl ester of 
XXIII) was prepared from (l-bromoethyl)benzene in the same way as 
the methyl ester of VI; yield 35 %, light yellow oil. 
URINARY MERCAPTURIC ACIDS 
The isolation of the metabolites from urine, the determination of 
the molar ratio of the mercapturic acids III, IV, V, VI and XXIII, 
and the total mercapturic acid excretion in urine were performed 
as mentioned previously in chapter 2.2.2. 
Standard series of the synthesized reference compounds added to 
urine samples and subjected to the same procedure, gave a recovery 
for compound VI of 61.8 _+ 1.2 % and for compound XXIII of 62.0 +_ 
1.0 % (each value % +; S.D. (n=4)). The results have been corrected 
for these values. 
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2.5.3 RESULTS 
T.I.e. as described in chapter 2.2.2 gave as Rn values for the 
methyl esters of III, 0.28; IV, 0.39; V, 0.45; VI, 0.63 and XXIII, 
0.65. respectively. The methyl esters of all isolated mercapturic 
acids were chromatographically identified by comparison with the 
synthesized reference compounds. The structures of the substances 
isolated from the urine were confirmed by 'H-n.m.r. and mass 
spectra. The n.m.r. data of the methyl ester of VI and XXIII are 
summarized in table 5, those of the methyl ester of IV have been 
described previously (chapter 2.2.3). 
TABLE 5 'H-n.m.r. data of the reference compounds. 
Assignment Methyl ester of VI Methyl ester of XXIII 
(p.p.m.)t (p.p.m.)t 
CgHgCHCH^ 
сосн3 
C6 H 5
C
»2 C»2 
CHSCH 
SCH CH 
соосн3 
S C H 2 C H 
NH 
c 6 « 5 
1.97 (s) 
2.65-2.90 (m) 
2.94 (d) (J=5.4 Hz) 
3.68 (s) 
4.67-4.93 (m) 
6.70 (d) (J=7.5 Hz) 
7.1-7.4 (m) 
1.54 (d) (J=7.0 Hz) 
1.92 (s) and 2.02 (s)t 
2.53-2.94 (m) 
3.72 (s) and 3.75 (s)t 
4.66-4.88 (m) 
6.05 (d) and 6.24 (d)t 
7.31 (s) 
Abbreviations: (s) singlet, (d) doublet, (m) multiplet 
t In CDC1 Internal reference: TMS 6=0.00 p.p.m. 
φ Diastereoisomers 
Integration of the signals correspond with the number of 
underlined protons. 
The mass spectra of the methyl esters of the isolated and 
synthetic metabolites were also identical. The mass spectra of 
the methyl ester of VI and XXIII are reproduced in figure 9. 
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Figure 9 Mass spectra of the reference compounds VI (top) and 
XXIII (bottom) 
After a single dose of (Z-bromoethyl)benzene (XXII) (0.81 mmol/kg) 
40.5 + 5.7 % of the dose was excreted as thioethers (n=5). Two 
mercapturic acids were isolated, the alkylmercapturic acid VI and 
the hydroxy-alkylmercapturic acid IV. The molar rat io of VI:IV 
amounted to 98:2. By means of chromatography no other mercapturic 
acids could be detected. After a single dose of (l-bromoethyl) 
benzene (XXI) (0.81 mmol/kg) 13.6 + 3.5 % of the dose was excreted 
as thioethers (n=8). Only alkylmercapturic acid XXIII could be 
isolated. No other mercapturic acids could be detected 
chromatographically. The mercapturic acid XXIII appeared to be a 
mixture of two diastereoisomers. I t should be mentioned that the 
bromide XXI was administered as the racemate. 
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2.5.4 DISCUSSION 
I f the f i r s t proposed pathway (GSH displacement of halogen, 
followed by hydroxylation) is the only route of metabolism after 
a dose of (2-bromoethyl)benzene (XXII) the excretion of the 
mercapturic acid IV in addition to VI might be expected, and 
after a dose of (l-bromoethyl)benzene (XXI), the mercapturic acid 
I I I in addition to XXIII. I f the second (dehydrohalogenation, 
epoxidation, GSH conjugation) or th i rd (hydroxylation, dehydro­
halogenation, GSH conjugation) pathway is the only route of 
metabolism or parallels the f i r s t one, the excretion of both the 
mercapturic acids I I I and IV in addition to VI is to be expected 
after a dose of (2-bromoethyl)benzene (XXII) and after a dose of 
(l-bromoethyl)benzene (XXI) the excretion of both the acids I I I 
and IV in addition to XXIII. The simultaneous occurrence of 
metabolites I I I and IV has not been observed and therefore the 
second and th i rd pathways can be excluded. In particular the non­
occurrence of compound I I I excludes these pathways, because this 
material was found as the dominant mercapturic acid from both 
23 styrene ( I ) and styrene oxide ( I I ) . This means that the 
metabolism of (l-bromoethyl)benzene and (2-bromoethyl)benzene 
proceeds by the displacement of the bromine atom by glutathione 
either spontaneously or by means of glutathione S-alkyl-
24 25 transferase. ' These conjugates are subsequently transformed 
to the acids VI and XXIII. The formation of product IV during the 
metabolism of (2-bromoethyl)benzene can be explained by a further 
hydroxylation of the displacement product VI. Alternatively, an 
α-hydroxy function is introduced in the bromoethylbenzene prior 
to displacement of the halide by glutathione. No conclusion can 
be drawn yet about the correct order of the hydroxylation 
reaction. In conclusion, our data clearly reveal that neither 
styrene nor i t s epoxide feature in the metabolism of these ary l -
alkylhalides in the rat. 
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PART III METABOLISM OF FUNCTIONALIZED OLEFINIC 
COMPOUNDS 
CHAPTER 3.1 Metabolism of ainnamia aldehyde and 
airmamyl alcohol 
CHAPTER 3.2 Metabol-iem of α, ß-imsaturated nitriles 
CHAPTER 3.3 Metabolism of acrylic esters 
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3 . 1 METABOLISM OF СІШАМІС ALDEHYDE AND CINNAMYL ALCOHOL 
3.1.1 INTRODUCTION 
Cinnamic aldehyde ( I ) is used as a sweetner and powerful spicy 
ingredient for household products, in detergents and soaps, in 
masking odors, and also extensively in flavor compositions. I t is 
a well-known compound in dermatology because of i t s i r r i t a n t and 
1 2 sensitizing capacity on human skin. ' I t has generally been 
accepted that the formation for allergenic act iv i ty of a covalent 
bond between a simple chemical and protein is required, in vitro 
studies showed that cinnamic aldehyde reacted with ε-amino groups 
of proteins, giving rise to the corresponding S c h i f f s bases 
which are believed to i n i t i a t e the observed allergenic hyper­
sensit iv i ty. ' Metabolic studies of Boyland and Chasseaud ' 
showed that cinnamic aldehyde reacts not only in an enzyme 
catalysed reaction but also spontaneously with glutathione in 
vitro and in vivo. Theoretically, an alternative mode of 
metabolism involves conjugation with protein nucleophilic groups 
subsequent to the addition to the carbon-carbon double bond of 
cinnamic aldehyde. 
The aim of the present investigations is to elucidate the 
metabolic biotransformation of the cinnamic aldehyde in vivo by 
isolating and identifying of S-containing metabolites. As cinnamic 
acid and cinnamyl alcohol can be expected to be intermediates in 
the metabolism of the aldehyde we also included these compounds 
in this study. 
3.1.2 MATERIALS AND METHODS 
CHEMICALS 
trans-Cinnamic aldehyde, cinnamyl alcohol, cinnamyl bromide, 
cinnamic acid and 3-phenyl-l-propanol were purchased from Aldrlch 
Europ.e (Belgium) . The cinnamic aldehyde and cinnamyl alcohol were 
freshly distilled before use. All the other chemicals were 
obtained from Merck A.G. (Germany) and were of pure grade. 
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ANIMAL TREATMENT 
Cinnamic aldehyde (250 mg/kg = 1.89 nunolAg), clnnamyl alcohol 
(125 mg/kg = 0.93 mmol/kg) and cinnamic acid (250 mg/kg = 1.69 
mmol/kg) were administered i.p., daily, 5 days a week, during 2 
weeks, in 1 ml arachis oil. 
Urine samples were collected daily over 1 ml 2 N. HCl, pooled and 
frozen immediately until required for analysis. 
Animals injected with the oil only served as control group. 
SYNTHESIS OF THE REFERENCE COMPOUNDS 
N-aaetyl-S-(l-phenyl-3-hydroxypropyl)cysteine methyl ester, 
aompound V: 
A mixture of 3-phenyl-l-propanol (13.4 mmol), t-butyl-dimethyl 
silyl chloride (17.9 mmol) and imidazol (33.5 mmol) was stirred 
at room temperature for one night. The silylated alcohol was 
isolated quantitatively by preparative HPLC (Yobin Yvon, 
miniprep. L.C. column material Merck Kieselgel Η (Typ 60) and 
di-isopropyl ether as eluent). The silyl ether was brominated 
with N-bromo-succinimide in dry CCI , in the presence of a 
catalytic amount of azoisobutyronitrile. After filtration and 
evaporation of the solvent in vacuo, the residue was resolved in 
dichloromethane. The silyl group was removed by adding an excess 
borontrifluoride etherate (IM in dichloromethane) at 0 C. After 
stirring for 10 minutes, the reaction mixture was neutralised 
with an aqueous solution of sodium bicarbonate. The organic layer 
was separated and the aqueous layer was extracted several times 
with chloroform. The combined organic layers were dried (MgSO.), 
filtered and concentrated in vacuo. The crude 3-phenyl-3-bromo-l-
propanol was obtained as an oil in 80 % yield. The methyl ester 
of N-acetyl cysteine (1 mmol), 3-phenyl-3-bromo-l-propanol (1 mmol) 
and triethyl amine (2 mmol) in 50 ml of methanol were stirred at 
room temperature for 65 hrs. After removal of solvent the 
N-acetyl-S-(l-phenyl-3-hydroxypropyl)cyeteine methyl ester (V) 
was obtained in 90 % yield, by preparative HPLC, using CHCl, as 
solvent. 
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N-aeetyl-S-(l-phenyl-2-aarboxy-ethyl)ay8teine dimethyl ester, 
compound VI: 
N-acetyl-cysteine methyl ester (0.02 mmol), trlethyl amine 
(0.03 mmol) and methyl clnnamate (0.02 mmol) were dissolved In 
50 ml of methanol, and the mixture was refluxed for 3 days. The 
mixture was evaporated to dryness in vacuo. The remaining oil 
was separated on preparative t.l.c. N-acetyl-S-(l-phenyl-2-
carboxy-ethyl)cysteine dimethyl ester (VI), was obtained as white 
crystals, melting from 52 -62 , yield 15 %. 
N-aaetyl-S-(3-phenyl-2-propenyl)cysteine methyl ester, compound 
VII: 
This material was prepared following the same procedure as 
described for compound VI, by taking cinnamyl bromide instead of 
methyl clnnamate as the starting material. The desired ester VII 
was obtained as white crystals, melting from 86 -88 , yield 87 %. 
DETERMINATION OF TOTAL THI0ETHER EXCRETION IN URINE 
Rats were treated with a single dose of сinnamiс aldehyde (I), 
cinnamyl alcohol (II) or cinnamic acid (III) (250 mg/kg). Total 
thioether excretion in the urine (24 hr) was determined as 
described in chapter 2.2.2. Standard series of synthesized 
reference compounds added to urine samples and subjected to the 
same procedure, gave a recovery for compound V of 37 +^  2 % and 
for compound VI of 70 +_ 1 %. The results have been corrected for 
these values. Information concerning the spectra measurement, 
isolation procedure and molar ratio determination are given in 
chapter 2.2.2. 
3.1.3 RESULTS 
After continuous dosage of trane-cinnamic aldehyde ( I ) , two 
sulphur containing metabolites could be isolated from the urine 
of rats. The methyl esters of the isolated metabolites were 
identical with the synthetic compounds V and VI, according to 
their mass spectra (represented in figure 1) and Rp values on 
t . l . c . (Rp 0 . 1 , compound V and Rp 0.26, compound VI, diethyl 
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Figure 1 Mass spectra of the reference compounds V, VI and VII 
ether as eluent, two times). After preparative t . l . c , followed 
by the thioether test on the separated compounds, the molar rat io 
of the mercapturic acids V and VI could be estimated. The experi­
ments were performed in duplo. The mean result was V:VI = 4 : 1 . 
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The structures of the metabolites were confirmed by 'H-n.m.r. 
spectra (summarized in table 1). Both the urinary and the 
synthetic compounds V and VI occurred as a mixture of two 
diastereoisomers, in the same rat io (1:1), as estimated by 
integration of the 'H-n.m.r. spectra. 
The dominant mercapturic acid of cinnamic aldehyde ( I ) , which was 
found to be N-acetyl-S-(l-phenyl-3-hydroxypropyl)cysteine methyl 
ester (V), could also be isolated and ident i f ied from urine of 
rats dosed with cinnamyl alcohol ( I I ) . In this case the n.m.r. 
spectrum showed a sl ight preference for one of the two 
diastereoisomers (1.6:1). The thioether excretion in the urine of 
rats dosed with cinnamic aldehyde amounted to 14.8 + 1.9 % (n=4). 
For cinnamyl alcohol this value was 8.8 + 1.7 % (n=4) of dose 
(125 mg/kg). Cinnamic acid showed no increase in the thioether 
excretion. Pretreatment of rats with pyrazole (206 mg/kg,i.p.) 
30 minutes before administration of cinnamyl alcohol (125 mg/kg) 
lowered the thioeter excretion signif icant ly from 8.8 + 1.7 % to 
3.3 + 1.4 % (n=4) of dose. 
Compound V I I , N-acetyl-S-(3-phenyl-2 propenyl)cysteine methyl 
ester, could neither be detected after dosage of cinnamic aldehyde 
nor after dosage of cinnamyl alcohol. Dosage of compound VII 
i t s e l f to rats (150 mg/kg) resulted in the excretion of two 
mercapturic acids. The major one was the unchanged compound VII 
and the minor was substance V I I , hydroxylated at the para position 
(rat io 7:1). 
3.1.4 DISCUSSION 
The results presented above reveal that cinnamic aldehyde ( I) is 
metabolized in the rat to two sulphur containing metabolites. The 
major metabolite is N-acetyl-S-(l-phenyl-3-hydroxypropyl)cysteine 
( V ) and the minor one is N-acetyl-S-(l-phenyl-2-carboxy-ethyl)cys-
teine ( Г ) . The n.m.r. spectra of the methyl esters of the isolated 
mercapturic acids indicate that the nucleophilic addition of 
glutathione had taken place at the ß-carbon atom of the carbon-
carbon double bond of cinnamic aldehyde. The structures of the 
metabolites also show that at some stage during the conversion of 
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TABLE 1 'H-n.m.r. data of the reference compounds 
ι 
αϊ 
о 
С
А 
с_н.сн=сн 
о 5 — 
с^н.сн^н 
6 5 — 
ΝΗ SCH0CH 
с
в
н
с
сн 
О О — 
С6 Н5 С5 
СН
о
0Н 
COOCHg 
СН=СНСН 
SCH2CH 
SCH2CH 
сн2соосн3 
SCH сн 
сн^сн^н 
—2 2 
NHCOCH. 
—3 
7.23 
6.15 
5.63 
3.47 
3.62 
2.41 
1.Θ6 
ν' 
(s) 
(d) & 6.40 
- 4.86 (m) 
- 4.136 
(s) & 3.70 
-
-
- 2.806 
(s) & 2.00 
(d)2 
(s)2 
(s)2 
7.30 
6.10 
4.66 
4.25 
3.63 
3.69 
2.79 
1.93 
VI' 
(s) & 7.32 
(d) & 6.48 
- 4.93 (m) 
(t)5 
(s) & 3.67 
(s) & 3.76 
-
-
- 2.886 
(s) & 2.09 
(s)2 
(d)2 
(s,2 
(s)2 
(s)2 
VII' 
7.26 - 7.36 
6.423 
6.20 - 6.38 
4.65 - 4.88 
3.75 (s) 
3.29 (d)4 
2.71 - 3.13 
2.02 (s) 
(m) 
(br) 
(m) 
(m) 
1) In CDCL , Internal reference: TMS 6 0.00 p.p.m. 
2) diaatereoisomers 
3 > JAB 1 β H21: 4 ) JBX 6 · 5 H z ; 5 ) J 7 H z ; 6 ) o v e r l a P 
(s) singlet, (d) doublet, (t) triplet, (m) multiplet, (br) broad 
Intégrâtlob of the signals corresponded with the number of underlined protons. 
the intermediate glutathione conjugate of cinnamic aldehyde (IV) 
into a mercapturic acid, reduction of the carbonyl function to a 
hydroxy methyl group occurs, whereas to smaller extent oxidation 
to a carboxylic group has taken place (see figure 2). Our results 
exclude that oxidation occurs prior to glutathione addition, as 
administration of cinnamic acid (III) showed no increased 
thioether excretion in the urine of rats. Recently,it was found 
that aromatic substituted aldehydes and their corresponding 
о 
alcohols can be metabolized to mercapturic acids. Sulphation of 
the alcohol r e s u l t i n g i n the formation of a s u l f a t e ester has 
been suggested to play a r o l e . Such proposed s u l f a t e esters are 
H»C.e 
CH 
II 
CH \ C-H 
/ 
н5с6 
fiH 
CH 
CH,OH II ι 
r - H^-ÇH-SG 
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Figure 2 Mercapturic acid formation of cinnamic aldehyde 
and cinnamyl alcohol 
-67-
known to be metabolized to mercapturic acids. However, the 
failure to detect N-acetyl-S-(3-phenyl-2-propenyl)cysteine ( І Г ) 
in the urine of rats exclude the metabolic sequence involving 
reduction, sulphation, glutathione conjugation for cinnamic 
aldehyde and cinnamyl alcohol. Dosage of cinnamyl alcohol (II) to 
the rats resulted in the detection of only one sulphur containing 
metabolite, namely N-acetyl-S-(l-phenyl-3-hydroxypropyl)cysteine, 
which was isolated as its methyl ester (V). In order to explain 
the formation of this metabolite a mechanism similar to that 
13 proposed for the biotransformation of crotyl alcohol and allyl 
14 
alcohol may be applicable. In the cited literature evidence 
has been presented that the corresponding aldehyde may be a 
possible intermediate in the conversion of the alcohol to its 
mercapturic acid. The proposed metabolic pathway for cinnamic 
aldehyde is in good agreement with the in vitro results; cinnamic 
aldehyde reacts spontaneously and enzymatically with 
glutathione. In contrast it was found that сіппащуі alcohol 
reacted neither spontaneously nor enzymatically with glutathione. 
The inhibition experiments of alcohol dehydrogenase by pyrazole, 
in vivo, showed a significant diminishing of the thioether 
excretion in the urine of rats (from 8.8 % to 3.3 %). These 
results are also in good agreement with the proposed metabolic 
pathway of сіппащуі alcohol to mercapturic acid via the 
intermediacy of cinnamic aldehyde. 
In conclusion, our experiments reveal that cinnamic aldehyde and 
cinnamyl alcohol react with glutathione, and result in the 
excretion of mercapturic acids in the urine of rats. Cinnamic 
aldehyde acts as a direct alkylating reagent by conjugate addition 
to the unsaturated enone system, while сіппащуі alcohol shows 
alkylating properties in a more indirect manner. Our findings 
point to the following consequences for the bio-system. In cases 
that the protective effect of glutathione is reduced, cinnamic 
aldehyde forms a double harm to proteins. Since it can covaiently 
bind to polypeptides by a conjugate addition of the nucleophilic 
-68-
group to the double bond of the unsaturated aldehyde. Especially 
thiol groups will be alkylated in this way, because they react 
under comparable physiological conditions some three hundred times 
as fast as amino groups. On the other hand, the aldehyde 
function in cinnamic aldehyde can also react with amino groups 
3 4 
resulting in a Schiffs base derivatives. ' Both reactions 
result in a protein conjugate, and consequently become a contact 
sensitizer. This may be one of the reasons why cinnamic aldehyde 
is such a potent contact sensitizer. 
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3.2 METABOLISM OF a,^-UNSATURATED NITRILES 
3.2.1 INTRODUCTION 
α,θ-Unsaturated ni t r i l es are very i n t e r e s t i n g compounds from a 
metabolic point o f view. Acryl om' t r i l e , an important i n d u s t r i a l 
monomer, bears a c e r t a i n s t r u c t u r a l resemblance to the well-known 
carcinogen v inyl c h l o r i d e , which is metabolized via an epoxide. 
On the other hand α,β-unsaturated n i t r i l e s can undergo a Michael 
a d d i t i o n react ion and thus act as d i r e c t a l k y l a t i n g agents. 
A c r y l o n i t r i l e is a d i r e c t l y act ing mutagen i n some stra ins of 
Escherichia c o l i . In the Ames t e s t however, a c r y l o n i t r i l e was 
2 3 
only mutagenic a f t e r metabolic a c t i v a t i o n ' , and the formation 
of an epoxide intermediate, 2 , 3 - e p o x y - p r o p i o n i t r i l e , has been 
4 
suggested although controvers ia l resul ts have been reported. 
Metabolic invest igat ions showed a deplet ion of g l u t a t h i o n in 
5 6 7 
vivo a f t e r admin istrat ion of a c r y l o n i t r i l e ' ' , and in vitro 
8 9 
a f t e r administrat ion of c innamonni t r i le . Langvardt et a l . 
recent ly confirmed the important ro le of g lutath ione i n the 
metabolism of a c r y l o n i t r i l e by i s o l a t i n g two sulphur containing 
metabol i tes. One of these appeared to be the cyanoethyl adduct of 
N-acetyl-cysteine, p o i n t i n g to d i r e c t a l k y l a t i o n of the t h i o l 
group of g lutath ione. The second metabol i te, t e n t a t i v e l y 
i d e n t i f i e d as 4-acetyl-3-carboxy-5-cyanotetrahydro-l, 
4-2H-thiazine, suggested the intermediacy of an epoxide. As Gut 
e t a l . have shown, a c r y l o n i t r i l e i s also p a r t i a l l y metabolized 
i n rats to cyanide i o n , which is then transformed to thiocyanate 
and el iminated i n the u r i n e . Aim of the present invest igat ions is 
to e luc idate the mechanisms of biotransformation of a,0-unsatura-
ted n i t r i l e s , and to study the influence of subst i tuents on the 
metabolic pathways. The formation of mercapturic acids 
(S-substituted-N-acetyl-L-cysteines) by rats was invest igated 
a f t e r admin istrat ion of a c r y l o n i t r i l e (AN), c r o t o n o n i t r i l e (ON) 
and cinnamonnitr i le (CiN). 
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3.2.2 MATERIALS AND METHODS 
CHEMICALS 
Acrylonitrile, crotononitrile and cinnamonnitrile were purchased 
from Janssen Pharmaceutica N.V. (Belgium). All other reagents 
used were of an analytical grade. 
SYNTHESIS OF REFERENCE COMPOUNDS 
The methyl esters of compounds N-acetyl-S-(2-cyanoethyl)-L-
cysteine (la), N-acetyl-S-(l-methyl-2-cyanoethyl)-L-cysteine (lb) 
and N-acetyl-S-(l-phenyl-2-cyanoethyl)-L-cysteine (Ic), were 
synthesized by addition of N-acetyl-L-cysteine methyl ester to 
the unsaturated nitriles (acrylonitrile and crotononitrile, 
respectively), in the presence of triethyl amine in refluxing 
methanol. No attempts were made to optimize yields. N-acetyl-S-
(2-hydroxyethyl)-L-cysteine (IIa), was synthesized as described 
by van Bladeren et al. The synthesis of N-acetyl-S-(l-methyl-
2-hydroxyethyl)-L-cysteine (lib) and of N-acetyl-S-(l-phenyl-2-
hydroxyethyl)-L-cysteine (lie), was carried as described in 
12 
chapter 2.2.2 , starting from styrene oxide and propylene oxide 
respectively. 
ANIMAL TREATMENT 
Adult female or male Wistar rats (+_ 200 g, TNO-stock, Zeist, 
Netherlands) were used. 
Rats were treated with a single dose of the unsaturated nitriles, 
orally using a stomach tube. 24 Hr urines were collected during 
three days. 
CHROMATOGRAPHY 
A carlo Erba 2300 gaschromatograph, equipped with FID, capillary 
WCOT-column coated with Carbowax 20 M, 8 m long, and a splitting 
liquid injection system was used. Temperature: injection port 
300OC, detector 260OC and column 1950C. A LKB-2091-2130 (EI/CI) 
GC/MS computer system was used for the identification of the 
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Compounds eluting from g.I.e. High Pressure Liquid Chromatography 
was performed as described in chapter 2.3.2. 
QUANTITATIVE DETERMINATION OF MERCAPTURIC ACID EXCRETION IN URINE: 
The mercapturic acids from acrylonitrile were determined by g.l.c. 
Urine was freeze-dried, taken up in 10 ml of methanol: diethyl 
ether (2:3) and 1 ml of this solution was treated with 
diazomethane, concentrated to dryness again and dissolved in 
0.5 ml of ethyl acetate. Before freeze drying 1 mg of the internal 
standard N-acetyl-S-(benzyl)-L-cysteine was added as a solution 
in 100 μΐ of water. 0.1 μΐ Of the ethyl acetate solution was 
analyzed by gaschromatography. The mercapturic acid excretion of 
crotononltrile and cinnamonnitrile as % of the dose was determined 
according to the method described in chapter 2.2.2. 
3.2.3 RESULTS 
Identification of meroapturia acids 
In urine of rats dosed with acrylonitrile, crotononitrile and 
cinnamonnitrile in each case two mercapturic acids were detected 
13 
on t.l.c. using the reagent of Knight and Young , and were 
isolated as the methyl esters using column chromatography and 
preparative t.l.c. They were identical in all respects with the 
reference compounds la', lb', Ic'' and IIa', IIb' and He' (Rf 
values, R t values, mass spectra and 'H-n.m.r. spectra, see tables 
1 and 2). Ic' and Ilc'occurred as a mixture of two diastereoisomers 
(as determined by n.m.r. and h.p.l.c, see tables 1 and 2). The 
ratio of the diastereoisomers of the isolated compound Ic' was 
2:1, while equal amounts of diastereoisomers were determined for 
compound He'. 
Influenae of dose on the excretion of mercapturic acids 
After oral administration of acrylonitr i le to male rats the 
influence of the dose on the ratio of compounds la and Ha and 
on the total excretion of mercapturic acid? in the urine was 
- 7 2 -
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TABLE 1 R values and mass spectrometric data of the reference compounds. R -CH2-CH(R )-
S-CH0-CH-NHCOCH_(COOCH ) 
Compound 
la' 
IIa' 
lb' 
lib' 
Ic' 
lie' 
R 
CN 
OH 
CN 
OH 
CN 
OH 
R 
H 
H 
сн
з 
С 6 Н * 
С6 Н5 
RT 
3.2β> 
1.47а) 
2.5а> 
1.5а> 
4.67, 5.11 
15.7, 17.6 
Other m/e values (rel. Intensities %) 
ι 
ω 
ι 
b) 
b) 
о.зо 
0.07 
0.22 
0.14 
0.29 
0.21 
с) 
d) 
,
d) 
d) 
230 ( 6) 
221 ( -) 
244 (24) 
235 ( 6) 
306 (10) 
297 ( 1) 
88 (100) 
144 (100) 
117 (100) 
143 (100) 
176 (100) 
267 (100) 
171 (44) 
203 (22) 
88 (61) 
217 (35) 
94 (37) 
176 (90) 
59 (40) 
162 (10) 
185 (57) 
176 (50) 
134 (34) 
144 (72) 
a) 
Ь) 
с) 
d) 
Determined by GLC 
Determined by HPLC, two diastereoisomers 
Ethylacetate as eluent 
Sequentially developed by hexane/diethylether 1:1, methanol/diethylether 4:96, diethylether 
1 2 
TABLE 2 The 'H-n.m.r. data of the reference compounds R -CH -CH(R )-S-CH -CH-NHCOCH3(COOCH ) 
Aesignment la' IIa' lb' lib' Ic ' He' 
7.35 (s) 7.32 (s), 7.33 (s) 
6.32 (d) 6.62 (d) 6.55 (d), 6.73 (d) 6.22 (d), 6.46 (d) 
n) 4.67-4.90 (m) 4.77-5.02 (m) 4.66-4.88 (m) 4.69-4.96 (m) 
4.0-4.26 (m) 3.8-4.2 (m) 
3.74-3.89 (m) 3.8-4.2 (m) 
3.75 (s) 3.78 (s) 3.68 (a), 3.75 (s) 3.71 <s), 3.76 (s) 
2.85-3.20 (m) 2.88-3.26 (m) 
2.84-2.92 (m) 2.86-2.97 (m) 
2.55 (d) 2.84-2.92 (ш) 
2.01 (s) 2.06 (s) 1.94 (s), 2.03 (s) 1.92 (s), 2.04 (s) 
1.35 (d) 1.31 (d) 
Abbreviations: (β) singlet, (d) doublet, (m) multiplet. In CDC1 , TMS = 0.00 ppm as internai standard. 
Integration of the signals corresponded with the number of underlined protons. 
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Investigated using g. I .e. The results are presented in figure 1. 
No signif icant difference could be observed in the rat io of 
metabolites la and Ha. However, the amount of mercapturic acid 
excreted showed a l i m i t of about 0.045 mmol in the f i r s t 24 hr 
urine. No further mercapturic acid excretion could be detected 
on the second day. 
The unsaturated n i t r i l e s were also administered to female rats in 
a low dose (0.05 mmol/rat) and a high dose (0.25 mmol/rat). A 
signif icantly lower percentage of the dose was excreted as 
0,15 0,20 0,25 
mmol of AN 
Figure 1 Dose-dependent excretion of mercapturic acids la and H a 
by rats dosed with acrylonitrile (AN). Each point is the 
mean + S.E. of at least six rats. •= Total amount of 
mercapturic acid; · = cyano mercapturic acid (la); 
о = hydroxy mercapturic acid (IIa) 
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mercapturic acids at the high dose level. The rat io of hydroxy 
and cyano mercapturic acids (compound I and I I ) did not change 
with dose (figure 2). However, a considerable influence of the 
C2-substituent (hydrogen, methyl and phenyl) on the relative 
amount of hydroxy compound I I was observed. 
50· 
•o 
Ol 
25 
I 
AN CrN CiN AN CrN ON 
0.05 mmol 0.25 mmol 
Figure 2 Differences in excretion of mercapturic acids la, lb, Ic 
and IIa, IIb, lic at a low dose (0.05 mmol/τat) and a 
high dose (0.25 mmol/rat). White = cyano mercapturic 
acid (la, lb, Ic) ; black = hydroxy mercapturic acid (Ha, 
lib, He) 
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Inhibition of oxidative metabolism 
Pretreatment of rats with 1-phenyl-imidazole (10 mg in 1 ml of 
DMSO per rat given oral ly (15)) one hr before administration of 
acrylonitr i le resulted in complete disappearance of the hydroxy 
mercapturic acid l a , as is shown in table 3. 
TABLE 3 Excretion of mercapturic acids la and IIa by rats dosed 
with acrylonitrile with and without pretreatment with 
1-phenyl-imidazole (50 mg/kg), dissolved in 0.5 ml of 
dimethylsulfoxide, 1 hr before administration of AN 
dose 
0 . 1 mmol 
0 . 2 mmol 
w i t h o u t a ) 
1 - p h e n y l - i m i d a z o l e 
Ia(CN)nimol IIa(OH)mmol 
0 . 0 3 9 + 0 . 0 6 0 . 0 1 6 + 0 . 0 4 
0 . 0 3 5 + 0 . 0 3 0 . 0 1 1 + 0 . 0 3 
w i t h a ) 
1 - p h e n y l - i m i d a z o l e 
Ia(CN)mmol IIa(OH)iiimol 
0 . 0 1 6 + 0 . 0 2 
0 . 0 9 9 + 0 . 1 0 
The mean _+ S.E. results of 6 rats are given. 
3.2.4 DISCUSSION 
With a l l three compounds investigated, the same types of 
mercapturic acids have been ident i f ied. The major metabolite was 
always the Michael adduct of the a,0-unsaturated n i t r i l e and 
glutathione (figure 3). In the case of acry loni tr i le this has 
g 
also been found by Langvardt et al. The isolation of a sulphur 
containing metabolite of cinnamonnitrile is in agreement with the 
о 
depletion of glutathione found for this compound by Chasseaud. 
The second metabolite contained a hydroxyl group instead of the 
cyano group. In the case of acrylonitrile this metabolite is 
identical with the compound which is the major metabolite of 
vinyl chloride , and also from dibromoethane. 
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Figure 3 The poss ib le pathways of biotransformation of 
a,B-unsaturated n i t r i l e s in to mercapturic acid 
Two metabolic pathways can be envisaged for the formation of the 
hydroxy mercapturic acids (figure 3). 
i) The first step in pathway A is the formation of a cyanoethyl 
adduct. The second step is the intramolecular substitution of the 
cyanide group by the sulphur atom giving rise to a thiiranium 
ion. Attack of water on this reactive intermediate results in the 
formation of a hydroxy mercapturic acid. The pathway which is 
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responsible for the mutagenicity of dibromoethane shows some 
s imi lar i ty. 
i i ) The f i r s t step in pathway В is the formation of a cyano- · 
epoxide. In analogy with the metabolism of vinyl chloride , 
attack of glutathione on this epoxide results in the formation of 
a cyanohydrin, which is in equilibrium with the corresponding 
18 aldehyde under expulsion of the cyanide ion. In a subsequent 
step the aldehyde is then reduced enzymatically to the hydroxy 
containing metabolite. 
The fact that the synthetic cyanoethyl mercapturic acids did not 
react with water under f a i r l y rigorous conditions (refluxing in a 
water/methanol mixture during several days) makes pathway A a less 
l ikely one. Moreover, cyanide ion is known to act as a good 
leaving group in a carbonyl forming elimination l ike in the 
18 conversion of cyanohydrols to aldehydes , but not in 
displacement reactions in simple al iphatic n i t r i l e s . 
Phenyl-imidazoles, originally developed as insecticide 
IP synergists " , are potent inhibitors of cytochrome P-450 dependent 
reactions. ' The observation that pretreatment of rats with 
1-phenyl-imidazole results in the total disappearance of the 
hydroxy mercapturic acid therefore supports strongly the 
intermedi асу of an epoxide. Moreover, the disappearance of hydroxy 
mercapturic acids was associated with an increase of the 
cyanoethyl mercapturic acid excretion. 
The relative amount of total mercapturic acid was approximately 
constant up to a dose of 0.10 mmol acry loni t r i le per rat (of 
200 g). At higher dose levels the amount of mercapturic acids 
seems to level o f f . An explanation can be found in the depletion 
of available glutathione, which is 0.05-0.10 mmol per total rat 
20 l i ver . A similar phenomenon has been observed in the case of 
11 21 
1,2-dibromoethane and cyclohexene oxide. Detoxification of 
both the reactive vinyl group and the proposed epoxide intermediate 
involves conjugation with glutathione. I t is therefore l i k e l y 
that the status of glutathione pools in target tissues may 
greatly affect the toxicity of these unsaturated n i t r i l e s . The 
ratio of the two mercapturic acids does not change s ignif icant ly 
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with dose. However, the nature of the substituent on the double 
bond, does exert a profound influence on this r a t i o . Cinnamon-
n i t r i l e and crotononitr i le give rise to much less hydroxy 
mercapturic acid in comparison to acry loni tr i le (9 % and 2 %, 
respectively). Thus, less epoxide is formed from substituted 
α,β-unsaturated n i t r i l e s . This may well be the result of steric 
hindrance, although the possibi l i ty of the occurrence of other 
pathways for the detoxif ication of the epoxides cannot be excluded 
at the moment. These experiments deserve further attention. 
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Figure 4 Metabolic pathways of α,β-unsaturated n i t r i l es 
The hydration of the epoxide, for instance, catalysed by the 
epoxide hydrolase, would result in a cyanohydrol, and 
subsequently in the formation of a cyanide ion and the 
corresponding α-hydroxy-aldehyde. in vivo the cyanide ion is 
transformed into thiocyanate, which has unequivocally been 
10 23 24 ident i f ied as a metabolite of acry loni t r i le. * ' From the 
spontaneous rearrangement of the epoxide, another possible 
- 8 0 -
transformation, cyanoacetaldehyde would be formed. Subsequently, 
this intermediate could be either reduced to cyanoethanol by the 
action of the soluble alcohol dehydrogenase or oxidized to cyano-
acetic acid by aldehyde dehydrogenase. Both compounds have been 
identi f ied after incubation of acrylonitr i le with rat l iver 
22 homogenate. (See also figure 4.) 
Interaction of glutathione with the epoxide intermediate has been 
shown to result in the formation of a hydroxy-mercapturic acid, 
via a ß-thiosubstituted cyanohydrol intermediate. Langvardt et al 
thought this intermediate to cyclize with loss of water to form, 
ultimately, N-acetyl-3-carboxy-5-cyano-tetrahydro-l,4-2H-thiazine 
(figure 4). We are inclined to doubt the ident i f icat ion of this 
metabolite of acry lon i t r i le , because contrary to our expectation, 
we were unable to detect this compound in our experiments, 
although + 20 % of orally dosed acry loni t r i le was supposed to be 
excreted as this urinary metabolite. Furthermore, as an authentic 
standard was not available for structural confirmation and 
attempts to obtain GC-IR data were unsuccessful, make the 
structural assignment by Langvardt et a l . questionable 
In conclusion i t is clear that conjugation to glutathione plays 
an important role in biotransformation of a,0-unsaturated 
ni t r i les. Two major routes of formation of mercapturic acids have 
been ident i f ied, one by direct conjugation and the other via an 
intermediate epoxide. α,β-Unsaturated n i t r i l e s thus seem to pose 
a t r i p l e threat to the organism: the unsaturated n i t r i l e i t s e l f 
can act as an alkylating agent, the epoxide is an even more 
reactive electrophile, and during the reactions of the epoxide, 
cyanide ion is released. 
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3.3 METABOLISM OF ACRYLIC ESTERS 
3.3.1 INTRODUCTION 
Acryl ate esters are the main ingredients in the formation of 
ac ry l i c res ins . The simplest representatives of the acry la te 
esters are methyl acry la te and methyl methacrylate. Another 
acry la te es ter , bet ter known as methyl cinnamate (methyl 0-phenyl-
ac r y l a te ) , is used i n fragrances and as f lavour ing food addi t ive 
since the 1920's. 
Workers i n the p las t i c industry have the r i sk o f being 
exposed to ac ry l i c monomers. However.also laboratory technicians 
and health profession personnel, who are involved w i th the 
manufacture of protheses, contact lenses and cosmetic products, and 
wi th the app l ica t ion o f coatings for ce l lu lose and t e x t i l e f i b r e s , 
glass and rubber, f requent ly are in contact wi th a c r y l i c esters. 
Some of the acry la te esters are v o l a t i l e and can produce 
tox ic e f fects by i nha la t i on . Animal experiments indicated that 
continuous absorption o f small doses of ac r y l i c esters may not 
2-5 
only damage the lungs, but also the l i v e r and kidneys. 
Teratogenic i ty in rats a f t e r in t raper i toneal admin is t rat ion o f 
esters o f methacryl ic acid has been reported. Also the 
occurrence of sarcoma i n rats a f te r subcutaneous app l ica t ion of 
7 8 
methyl methacrylate has been observed. ' I r r i t a n t contact 
dermat i tus, contact hypersens i t i v i t y , depending on dosage and 
repe t i t i on of the exposure, occur in humans a f t e r exposing the 
9-12 
skin to ac ry l i c es ters . With bu tad iy l - and hexadiyl 
d iacry lates a retarded and severe skin t o x i c i t y has been demon-
13 
s t ra ted i n humans. 
A major metabolic pathway in the biotransformation of ac ry l i c 
esters is a carboxyl esterase catalysed hydro lys is . " This 
biodégradation leads to de tox i f i ca t i on . I n h i b i t i o n o f the carboxyl 
esterase by t r i ( o r t f o - t o l y l ) phospha te (TOTP) enhances the 
t o x i c i t y of a number o f acry la te esters. 
Boyland and Chasseaud reported depletion o f g lutath ione levels i n 
l i v e r homogenates by ethyl cinnamate, ethyl acry la te and to a 
lesser extent by ethyl crotonate. Remarkably,they found no 
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deplet ion o f g lutathione a f te r incubation wi th methyl methacryl-
ate as substrate. However, i n a l a t e r repor t , they showed that 
a f te r in t raper i tonea l admin is t ra t ion, methyl methacrylate lowered 
the non-protein t h i o l levels i n ra t l i v e r w i th in two hours to 
68 % and they suggested the formation of a mercapturic acid in 
vivo. The react ion of methyl acryl a t e , methyl methacrylate and 
ethyl acryl ate wi th glutathione in vitro was confirmed by 
19 Hashimoto and Aldr idge. 
In r e l a t i v e l y few b io t rans fomat ion studies on acryl ates the 
i so la t i on and i d e n t i f i c a t i o n of t h e i r metabolites has been 
mentioned. B ra t t and Hathway found that up to 88 % of a s ing le 
14 dose of labeled methyl methacrylate in rats was expired as CO-
20 in 10 days. In the urine of these rats very low doses of 
methacrylic a c i d , e-hydroxy-isobutyric a c i d , methylmalonic a c i d , 
methylmalonic semialdehyde and succinic acid (<1 % of dose) were 
14 detected. For methyl acrylate the CO, exp i ra t ion amounted to 
21 
35 % of the dose i n three days. The dominant ur inary meta-
bo l i tes of methyl cinnamate were benzoic acid and hippur ic ac id . 
In rats and rabbi ts the benzoic acid was not only conjugated wi th 
22 glycine but also wi th glucuronic ac id . Small amounts of 
various phenolic metabolites were i d e n t i f i e d inc luding 4-hydroxy, 
3,4-di hydroxy- and the isomeric monomethyl ethers of 3,4-dihydroxy 
der ivat ives o f cinnamic ac id , i.e. p-coumaric a c i d , ca f fe ie a c i d , 
23 f e r u l i c acid and i so fe ru l i c ac id . Also p-hydroxybenzoic acid 
has been found. 
The aim of the present study i s to detect , i so la te and 
characterize su l f u r containing metabolites that may ar ise from 
the in te rac t ion of acry late esters w i th glutathione and to 
corre la te the f indings with the bio-behaviour of the unsaturated 
compounds invest igated in the previous chapters. The fo l lowing 
substrates were selected for th is i nves t i ga t i on : methyl acry la te 
( I ) , methyl methacrylate ( I I ) , methyl crotonate ( I I I ) , methyl 
cinnamate ( V I I ) , methyl atrópate ( V I I I ) and a series a c r y l i c 
esters of homologous alcohols (methanol-octanol). 
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3.3.2 MATERIALS AND METHODS 
CHEMICALS 
Methyl methacrylate, n.butyl and n.octyl acrylate were 
commercially available (Boom, Meppel, The Netherlands). n.Hexyl 
acrylate was purchased from Polysclences. Methyl clnnamate, 
methyl acrylate, methyl crotonate and Diazald (N-methyl-N-nitroso-
p-toluenesulphonamlde, precursor of dlazomethane) were purchased 
from Janssen Pharmaceutlca N.V. (Belgium). TrUortho-tolyl) 
phosphate (TOTP) was obtained from Eastman Kodak (USA). The 
acrylic esters which were not commercially available were prepared 
according to two methods. Firstly, by transesterification of 
methyl acrylate and methyl methacrylate, respectively, with the 
respective alcohol using p-toluene sulfonic acid as 
24, 25 
catalyst. Secondly, by treatment of acryloyl chloride and 
methacryloyl chloride, respectively, with the required alcohol in 
the presence of triethylamine and the acyl transfer catalyst 
27 
26 
4-(dimethylamino)pyridine. Glycidlc acid was prepared by 
oxidation of glycidaldehyde with H 0„(30 %) in basic medium. 
Methyl α-methyl glycidate was obtained by epoxidation of methyl 
28 
methacrylate with m-chloropenberzoic acid. Methyl ß-phenyl-
glycidate was prepared by a Darzens condensation of benzaldehyde 
with methyl chloroacetate using sodium methoxide as the base. 
α,ß-Dihydroxy-isobutyric acid was synthesised by converting 
acetolformiate into o,S-dihydroxyisobutyronitrile which then was 
29 hydrolysed in an acid medium. α,ß-Dihydroxybutyric acid was 
synthesised by hydroxylation of crotonic acid with tungsten acid 
30 
and hydrogen peroxide. ß-Phenylglyceric acid was synthesised 
by hydroxylation of cinnamic acid using KMnO. in C0o / acetone, 
4 2 
at -40OC. 
The Identity of the compounds was verified by mass spectrometry 
and their purity was ascertained by g.l.c. 
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SYNTHESIS OF THE REFERENCE COMPOUNDS 
Synthesis of methyl substituted N-acetyl-S-(oarboxy ethyl) 
cysteine dimethyl esters (IV, V and VI): 
A mixture of 10 mmol of methyl acrylate (I), methyl methacrylate 
(II), or methyl crotonate (III), 10 mmol of N-acetyl-cystelne 
о 
methyl ester and 20 mmol of trlethylamlne were kept at 100 С In 
50 ml of p-dloxane for 2 h. After cooling the mixture was 
evaporated in vacuo to dryness. An oily residue remained which 
was purified by t.l.c. with the eluent (B). R values: dimethyl 
F 
ester IV 0.20, V 0.21 and VI 0.26, respectively. 
Synthesis of methyl substituted N-aaetyl-S-(aarboxy ethyl)cysteine 
monomethyl esters (IV*", V' and VI'): 
These materials were prepared following the same procedure as 
described above, by taking N-acetyl cysteine instead of its methyl 
ester as the starting material. The desired esters were purified 
by t.l.c. with eluent (A). R values: monomethyl ester IV'" 0.31, 
F 
V' 0.37 and VI' 0.38, respectively. 
Synthesis of methyl substituted N-acetyl-S-(carboxy ethyl)cysteine 
dicarboxylic acids (IV", V" and VI1'): 
The diacids were synthesised from the corresponding dimethyl 
esters by keeping a solution in methanol with excess sodium 
hydroxide overnight at room temp., neutralizing with hydrochloric 
acid, concentration in Vacuo and subsequent purification of the 
remaining oil by t.l.c. with eluent (A). R_ values: dicarboxylic 
acid IV" 0.16, V" 0.17 and VI" 0.15, respectively. 
Synthesis of phenyl substituted N-aaetyl-S-(aarboxy ethyl)ay steine 
dimethyl esters (IX and X): 
0.02 Mol of methyl atrópate (methyl o-phenylacrylate), (VIII), 
0.02 mol of N-acetyl cysteine methyl ester and 0.03 mol of 
trlethylamlne were dissolved in 50 ml of methanol. The reaction 
mixture was kept at room temp, for one day. The mixture was 
concentrated to dryness in Vacuo. The remaining oil was separated 
by t.l.c. with eluent (C). 
N-acetyl-S-(2-phenyl-2-carboxy-ethyl)cysteine dimethyl ester 
(R 0.34) (X) was obtained as oil, yield 80 %. 
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The synthesis of N-acetyl-S-(l-phenyl-2-carboxy ethyDcysteine 
dimethyl ester (R 0.39) (IX) is described in chapter 3.1. 
F 
THIN LAYER CHROMATOGRAPHY 
Analytical t.l.c. was performed on silica gel pF„,. layers 
(0.25 mm). The eluent was (A) dichloromethane : methanol : acetic 
acid = 40 : 4 : 1 (v/v), (B) diethyl ether, or (C) diethyl ether : 
methanol =96 : 4 (v:v). 
0.5 Mm layers were used for preparative chromatography with the 
same eluents. After development of the plates, the spots were 
detected by fluorescence quenching (254 nm) and by spraying with 
31 
the reagent of Knight and Young. 
GAS LIQUID CHROMATOGRAPHY 
This type of chromatography was carried out with a HP 5750 gas 
Chromatograph equipped with an Atomaire Flame Ionisation 
Detection, a clean glass injection port and a glass column of 
1.8 m length, 3 mm int. dìam. containing 3 % OV-17 on gaschrom Q 
о 80-100 mesh, under the following conditions: column temp. 50 or 
70 C, injection block 200 C, detector 240OC, He carrier flow 
60 ml/min. The detection limit of the investigated epoxides and 
diol esters was about 20 mnol. 
HIGH PRESSURE LIQUID CHROMATOGRAPHY 
A Hewlett-Packard 1084 В high pressure liquid Chromatograph 
equipped with a microprocessor and an automatic sampling system 
was used. The variable wave-length UV detector was used and 
operated at 220 and 280 nm. The column was a 15 cm χ 4.6 mm I.D. 
stainless steel tube packed by the slurry technique with 
Lichrosorb RP 18 (5 ym) and operated at 30 C. The elution solvent 
consisted of a mixture of methanol and citrate buffer pH 6.5 
(ultimate concentration 0.01 Μ), volume ratio 2:98. Elution was 
performed at a flow rate of 1.5 ml/min. Under these conditions the 
retention times of β-phenylglycidic acid and ß-phenylglyceric 
acid were about 19.0 and 6.1, respectively. 
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ANIMAL TREATMENT 
Adult female and male Wlster rats (.+ 200 g, 6 weeks old) were 
used. They were housed in stainless steel metabolism cages and 
had free access to food and water. The methyl esters of acrylic 
acid (I), methacryllc acid (II), crotonic acid (0.14 mmol/kg) 
(III), cinnamic acid (1 mmol/kg) (VII) and atropic acid (0.2 
mmol/kg) (VIII), dissolved in arachis oil, were administered i.p. 
5 days per week for 3 weeks. For the isolation of the mercapturic 
acid of methyl methacrylate the dose was increased to 0.70 mmol/ 
kg daily. In inhibition studies the animals were injected with 
IOTP (0.34 mmol/kg) 18 h previous to Injection with the respective 
acrylic esters. Depending on the experiment, controls were 
injected with either oil or T0TP in oil only. The animals used 
for the in vitro experiments in inhibition studies were injected 
with T0TP 18 h before decapitation. 
ENZYME SOURCE 
Rats were decapitated between 8 and 10 a.m. The livers were 
perfused in situ with physiological saline solution, removed and 
stored on ice. For the experiment 4 livers were pooled and 
homogenized in 3 volumes of 1.15 % cold KCl solution with a 
Potter Elvehjem homogenizer. The homogenate was centrifugea at 
9000 g during 45 min. The supernatant was used as the enzyme 
source. There were no differences with respect to glutathione S-
transferase activities between this supernatant and a 105.000 g 
supernatant. The whole procedure was performed at a temperature 
between 0 and 5 С. 
DETERMINATION OF ENZYMIC GLUTATHIONE CONJUGATION Iff VITRO 
The reaction mixtures contained 1 mM GSH and 1 mil of the acrylic 
esters. The buffer was 0.1 M KH PO / Na ΗΡΟ , pH 7.4, and the 
total incubation volumes were always 1 ml. Mixtures were pre-
incubated for 5 minutes and the reaction was started by adding 
the substrate (in 25 μΐ acetonitrile). Incubation took place at 
о 37 С in a shaking water bath for 5 min. The reaction was stopped 
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by addition of 1.5 ml of a solution consisting of 120 g of NaCl, 
6.68 g of metaphosphoric acid and 0.8 g of EDTA, dissolved in 
distilled water to 400 ml, and followed by centrifugation for 10 
min at 600 g. Appropiate samples in each experiment served as 
blanks and for the determination of the non-enzymic reaction. The 
non-protein SH-concentration was determined spectrophotometrically, 
32 
according to Eliman. The protein content in the reaction 
mixture was 7-9 mg/ml. 
ENZYMATIC OXYDATION OF ACRYLIC ESTERS IN VITRO 
Microsomal preparations were obtained in the standard manner from 
the post-mitochondrial fraction of a 3 vol. homogenate of the 
liver from female Wistar rats, weighing 180-200 g. The rats were 
pretreated with phénobarbital (80 mg/kg, i.p.) during three days. 
The microsomal preparation was washed with 20 vol. of isotonic 
KCL, and then suspended in 0.1 И phosphate buffer, pH 7.4, to 
contain 7 mg of protein/ml. Protein was determined by the method 
33 
of Lowry et al. 
For the study of the microsomal oxidative metabolism of the 
acrylate esters, the complete incubation system consisted of the 
microsomal suspension (2 mg of protein/ml), NADP (0.33 mM), 
glucose 6-phosphate (8 mM), glucose 6-phosphate dehydrogenase (2 
lU/ml), EDTA (0.1 mM), 0.1 M phosphate buffer, pH 7.4 and 
acetonitrile (<2 %, v/v). The substrates were dissolved in 
acetonitrile and incubated with the microsomal solution for 1 h 
(max) at 37 C. The reaction mixture was extracted twice with 
ethyl acetate. The combined organic layers were concentrated and 
the residue was dissolved in 100 μΐ of methanol for subsequent 
g.l.c, g.l.c.-m.s. and h.p.l.c. analyses. For study of the 
microsomal hydrolysis of the corresponding epoxides, the epoxy 
substrates were incubated with microsomal suspensions in airtight 
о flasks at 37 С in 0.1 M phosphate buffer, pH 7.4, containing the 
substrates dissolved in methanol (<2 %, v/v). 
-90-
3 . 3 . 3 RESULTS AND DISCUSSION 
Depletion of glutathione in vitro and the meroapturia acid 
excretion in vivo of aorylia esters. 
The resul ts fo r the deplet ion of g lutath ione in vitro and the 
mercapturic acid excret ion in vivo obtained fo r the respective 
substrates, are compiled i n two tab les , vis. I l l and IV. For a 
proper discussion of the resul ts obtained wi th the various 
aorylia esters i t is o f c ruc ia l importance to establ ish the 
s t ructure of the excreted mercapturic acids. The th ioether 
containing materials iso lated from the ur inary excretes were, 
a f t e r treatment wi th diazomethane, compared wi th au thent ica l l y 
prepared reference samples. The 'H-n.m.r. spectral data of these 
reference compounds are co l lec ted i n the tables I and I I . The 
mass spectra of these compounds are p ictured i n the f igures 1 and 
2. The chromatographic Rp-values are mentioned i n the experimental 
sect ion. I t was found that the iso la ted substances a f te r diazo-
methane treatment, were ident ica l i n a l l respects wi th the 
reference compounds, the dimethyl esters IV, V, V I , IX and X. 
On the basis of the structures of these mercapturic acids the 
important conclusion can be drawn that these compounds ar ise from 
a conjugation of glutathione with the ac ry l i c esters in a Michael 
fashion, i.e. conjugate 1.4-addit ion to the a.B-unsaturated ester 
system. 
The excreted materials were ca re fu l l y screened fo r other 
types of mercapturic acids. Par t i cu la r a t ten t ion was given to 
hydroxy containing mercapturic acids that might ar ise from 
glutathione conjugation of a,e-epoxyesters (commonly ca l led 
g lyc id ic es te rs ) . Such epoxides are potent ia l primary metabolites 
of unsaturated esters . However, no such meroapturia acid could be 
detected. Therefore, the intermediaoy of glyoidio esters in the 
biotransformation of acrylic esters may be considered as highly 
unlikely. Nevertheless, there is s t i l l a p o s s i b i l i t y that such an 
epoxide w i l l be el iminated by a deviat ing metabolic pathway. This 
question is t reated in more deta i l a t the end of t h i s chapter 
during the discussion of the b io log ica l fa te of g l yc id i c esters . 
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TABLE I 'H-n.m.r. data of the methyl esters of the mercapturic acids derived from methylacrylate (IV), 
methyl methacylate (V) and methyl crotonate (VI). 
Assignment Dimethyl ester of IV 
p.p.m. 
Dimethyl ester of V 
p.p.m. 
Dimethyl ester of VI 
p.p.m. 
1 
(0 
1 
NH 
CH 
осн3 
осн3 
CH 2 -S 
S-CH 2-
S-CH 2-
S-CH-
•™2 
-CH 
сн2-соосн3 
NH-CO-
•
с
аз 
CH-CH„ 3 
6 . 3 
4 . 7 
3 . β 
3 . 7 
2 . 9 
2 . 5 
2 . 0 
- 6 . 5 ( b r ) 
- 4 . 9 (m) 
( s ) 
( s ) 
(d ) ( J = 6 Hz) 
- 2 . 8 (m) 
( s ) 
6.3 - 6.5 (br) 
4.7 - 4.9 (m) 
3.8 (s) 
3.7 (s) 
3.0 (d) (J = 5 Hz) 
2.6 - 2.9 (m) 
2.0 (s) 
1.23 (d) (J = 7 Hz) 
6.3 - 6.5 (br) 6.6 - 6.8 (br) 
4.7 - 5.0 (m) 
3.71 (d)2 
3.66 (s) 
3.0 (d) (J = 5 Hz) 
2.9 - 3.3 (m) 
2.4 (d) (J 
2.03 (d)2 
6 Hz) 
1.32- (d) (J = 5 Hz) 
Abbreviations: s = singlet, d = doublet, m = multiplet, br = broad. 
The n.m.r. spectra were measured in CDCl , internal references: TMS, S = 0.00 p.p.m. 
2 = 2 dlastereoisomers 
Integration of the signals correspond with the number of underlined protons. 
relative abundance (·/·) 
100 τ 
во 
ÇHj-S -сн
а
-сн-соосн, 
CHj NH<-CH1 
¿оосн, b 
\ .r 
во 
во-
40 
20 
ÇHrSOVÇH-ODOCH, 
H^-CH NH-C-CH, 
¿OOCH, 4 
IUI 1 -X-
Hf-ÇH· S-CWj-CH-COOCH, 
¿H, fîtH-C-CH, 
COOCH. о 
Ш 
юо 
300 
m/e 
Figure 1 Mass spectra of methyl ester of the mercapturic acids 
derived from methyl acrylate (IV), methyl methacrylate 
(V) and methyl crotonate (VI) 
As a consequence of the use of diazomethane during the isolation 
procedure, i t is not possible to deduce in a direct manner which 
part of the mercapturic acids is actually excreted as the free 
acid and which part as the alkyl ester. For methyl acrylate this 
problem was solved by using a radio-active label. After admini-
14 
stration of methyl acrylate labelled with С the radioactivity 
of the chromatographically separated mercapturic acids was 
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Figure 2 Mass spectra of the methyl e s t e r s of the mercapturic acids 
derived from methyl сinnamate (IX) and methyl atrópate (X) 
determined. From these data the ratio of excreted dicarboxyl acid 
and monomethyl ester was estimated to be 20:1. When a pretreatment 
with TOTP was applied the ratio was 1:2. In a l l cases the results 
are averaged over determination -in triplo in pooled urine. 
In the case of ethyl atrópate the fraction of excreted free 
acid was determined as follows. The thioether containing fraction 
of urine of rats dosed with ethyl atrópate, after pre-administra-
tion of TOTP, consisted of a mixture of two mercapturic acid 
esters (the urine fraction was treated with diazomethane). One 
was identi f ied as N-acetyl-S-(2-phenyl-2-carb0metfexci/-ethyl ) 
cysteine methyl ester and the other one as N-acetyl-S-(2-phenyl-
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Z-oarboethoxy-ethyì)cysteine methyl es ter . Their r a t i o of 1:2 was 
deduced from the in tegra t ion of 'H-n.m.r. signals of the carbo-
methoxy and carboethoxy groups. Without esterase i n h i b i t i o n only 
one mercapturic acid ester was i so l a ted , namely N-acetyl-S-(2-
pheny'l-Z-aarboxymethyl)cysteine methyl es te r , ind ica t ing tha t the 
actual excrete consists predominantly of the f ree d iac id . These 
resul ts obtained wi th ethyl atrópate match wel l wi th those of 
methyl acryl a te . 
On the basis o f the resul ts described above i t may be 
concluded that upon i n h i b i t i o n of the esterase a c t i v i t y the major 
actual mercapturic acid is a conjugate of the acrylate in which 
the ester funct ion is reta ined. In the absence of an esterase 
i n h i b i t i o n the excreted mercapturic acid is a formal conjugate of 
the free ac r y l i c ac id . I t is c lear that the ac ry l i c ester has 
been hydrolyzed by esterase after the acry late was bound to 
g lutath ione. Di rect hydro ly t ic cleavage of acrylates wi th esterase 
leads to ac ry l i c acid which w i l l be fu r the r metabolized to amongst 
21 
others carbon d iox ide. 
The 'H-n.m.r. spectrum of the mercapturic acid ester derived from 
methyl cinnamate showed the presence of the two diastereoisomeric 
forms as well as fo r the material i so la ted from urine as fo r the 
synthet ic reference compound. I n te res t i ng l y , the isomeric r a t i o 
of the ur inary substance as estimated from the appropriate n.m.r. 
s igna ls , amounted to 2 : 1 , while in the synthet ic material t h i s 
r a t i o was 1 :1 . This f ind ing suggests a stereoselect ive behaviour 
of the glutathione S-transferases towards conjugation of 
glutathione to methyl cinnamate. Unfortunately, the diastereo-
isomeric mercapturic acids of methyl methacrylate, crotonate and 
atrópate did not show up d i f f e ren t l y in the n.m.r. spectra. 
Therefore, the s te reose lec t i v i t y , i f present, could not be 
deduced. Possibly, other analy t ica l techniques l i k e h . p . l . c . are 
more successful in d i f f e r e n t i a t i n g the diastereoisomers. I t would 
be of i n te res t to shed l i g h t on the stereo-chemical course o f the 
glutathione conjugation process. 
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TABLE II 'H-n.m.r. data of the methyl esters of the mercapturlc 
acids derived from methyl cinsamate (IX), and methyl 
atrópate (X). 
с
б5 5 
NH 
SCH2CH 
COOCH 
C6 H5 C« 
7.30 
6.18 
4.65 
3.63 
3.69 
4.25 
IX 
(s) fc 7.32 
(d) & 6.48 
-4.88 (m) 
(s) & 3.67 
(s) & 3.75 
(t) 
(s) 2 
(d) 2 
(s) 2 
(s) 
X 
7.30 (s) 
6.70 (d) 
4.62 - 4.89 (m) 
3.68 (s) & 3.72 (s) 
3.74 (s) 
C6 H5 Cä 
C H 2 S C H 2 
SCINCH 
CHoC00CH_ 
NHCOCH 
2.79 - 2.88 (m) 
1.93 (s) & 2.09 (s) 
2.87 - 3.19 (m)" 
2.04 (s) 
1) in CDC1 , internal reference: TMS δ = 0.00 p.p.m. 
2) 2 diastereoisomers 
3) overlap 
(s) singlet, (d) doublet, (t) triplet, (m) multiplet 
The integration of the signals correspond with the number of the 
underlined protons. 
In order to discuss the data collected in the tables I and I I i t 
should be kept in mind that the mercapturic acids isolated in the 
in vivo experiments arise from the glutathione conjugation 
direct ly with the unsaturated esters and that glycidic esters 
apparently do not play a role in the bioelimination of acrylic 
esters. Consequently, two metabolic pathways for the disposition 
of acrylic esters have to be considered, viz. hydrolysis by 
esterase and glutathione conjugation. The hydrolysis can be 
blocked by pretreatment of the animals with TOTP, a carboxyl 
esterase inhibi tor. 
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TABLE III Depletion of glutathione in vitro and the mercapturic acid excretion in vivo: The reactivities 
of the substituted acrylate esters with glutathione were compared at pH 7.4 after a 5 min 
incubation at 37 C. The results are the mean value of a determination in triplo. Livers of 
several animals used for this experiment were pooled and homogenized (n=4, S.D. <3 % ) . 
2 1 
R HC=CR -COOR GSH depletion GSH depletion in liver Mercapturic acid excretion 
R2 
H 
H 
сн
з 
H 
C6 H5 
R1 
H 
сн
з 
H 
C6 H5 
H 
R 
сн3 
C H3 
сн
з 
C2 H5 
C2 H5 
in rat liver 
homogenates 
41* 
0 
5 
32* 
8 
homogenates of rats 
pretreated with TOTP 
as percentage of dose 
(0.14 mmol/kg) (mean _+ S.D.) 
pretreatment with 
TOTP 
ι 
« 
I 
67 
2 
13 
44* 
32 
6.6 + 0.6 
2.0 + 0.6 
10.4 + 1.9 
1.5 + 0.4 
40.6 + 2.1 
11.0 + 3.3 
16.0 + 2.0 
14.8 + 2.4* 
22.8 + 5.9 
The GSH depletion is expressed as % decrease of the initial amount 
A non enzymatic reaction amounted to β % of the initial amount of GSH 
A maximum dose should not exceed 0.14 mmol, to prevent mortuality of the rats. 
The data i n the tables I I I and IV reveal that i n a l l cases the 
glutath ione deplet ion increases a f t e r esterase i n h i b i t i o n , 
confirming the competative behaviour of the carboxyl esterase i n 
the b i o e l i m i n a t i o n of the acry late substrates. A s i m i l a r pattern 
i s observed f o r the ur inary mercapturic acid excret ion by 
comparing the t h i r d and f o u r t h column i n the tables I and I I . The 
amount of mercapturic acids excreted i n r a t ur ine i s enhanced 
a f t e r pretreatment of the rats with TOTP compared w i t h the amount 
of ur inary mercapturic acids found without esterase i n h i b i t i o n . 
The data i n table I I I i n d i c a t e that introduction of a substituent 
at the double bond of the parent acrylate esters, e i t h e r at the α 
or at β pos i t ion diminishes the rate of g lutath ione conjugation 
catalysed by glutathione S-transferases. Furthermore, the data 
show that the phenyl s u b s t i t u t e d acryl a t e s , ethyl cinnamate and 
ethyl atrópate,are bet ter substrates fo r the glutathione conjuga-
t i o n than the methyl subst i tu ted acry la tes , methyl methacrylate 
and methyl crotonate. I t should be noted, that both in the 
g lutath ione deplet ion and the mercapturic acid excret ion methyl 
acry la te and ethyl atrópate occupy a special p o s i t i o n . In addi t ion 
to the catalysed glutathione conjugation also a spontaneous 
react ion with glutathione was observed. Therefore, a random 
a l ky la t i on of nucleophi l ic s i tes must be expected in vivo. The 
inf luence of the s t ruc tu ra l di f ference of the various ac ry l i c 
esters on the glutathione conjugation is d i f f i c u l t to account f o r . 
The resul ts obtained fo r the acrylates of homologous alcohols 
( tab le IV) show that the amount of glutathione conjugation 
depends on the chain length o f the ester group. The reason f o r 
the reduced r e a c t i v i t y of glutathione conjugation wi th increasing 
chain length of the esters must be due to the enzymatically 
catalysed reac t ion , since the amount of the non-enzymic conjuga-
t i o n was i n the same order o f magnitude fo r a l l substrates (+ 8 % 
34 — 
depletion in 5 minutes). I t is known from l i terature that 
certain S-substituted derivatives of glutathione inh ib i t the 
glutathione S-transferase. This inhibitory effect appeared to be 
stronger with increasing hydrophobicity. As an explanation of 
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TABLE IV Depletion of glutathione ги ъЬго and the mercapturic acid excretion гп vivo of acrylate 
esters of homologous alcohols 
CH =CHCOOH GSH depletion in rat GSH depletion in liver Mercapturic acid excretion 
liver homogenates homogenates of rats 
pretreated with TOTP 
Pretreatment 
as % of dose (0.70 mmol/kg, with TOTP 
n=4, mean ¿S.D.) (0.14 mmol/кg) 
ι 
(О 
ID 
I 
сн„ 
C2 H5 
С3 Н7 
С4 Н9 
С5Н11 
С6Н13 
С8Н17 
41 
31 
26 
16 
15 
18 
8 
67 
51 
40 
42 
34 
33 
13 
6.6 + 0.6 
7.1 + 1.6 
6.2 + 1.1 
4.0 + 0.8 
3.4 + 1.2 
4.0 + 0.8 
2.0 + 0.8 
40.6 + 2.1 
44.0 + 2.2 
38.0 + 2.3 
38.1 + 2.5 
36.0 + 1.1 
21.5 + 2.1 
14.1 + 2.0 
The GSH depletion is expressed as percentage decrease of the initial amount 
The non-enzymatic reaction was for all compounds the same, and amounted to 8 % of the initial amount. 
this phenomenon i t was suggested that the substrate and the 
glutathion conjugate are competing for the same s i te of the 
enzyme. The a f f in i t y for this site was enlarged with increasing 
hydrophobicity. Using a similar model for the explanation of the 
above mentioned results i t may be that acrylic esters with 
increasing chain length inh ib i t indirectly their own enzymatically 
catalysed conjugation with glutathione. The observed pattern in 
the glutathione conjugation was also encountered, but less 
pronounced in the thioether excretion. 
In the in vivo experiments the possibi l i ty exists that part 
of the glutathione conjugates wi l l be excreted via the bi le into 
the faeces. Analysis of faeces of rats dosed with methyl acrylate, 
butyl acrylate or octyl acrylate showed not a signif icant 
increased thioether amount, v/hich excludes this route as a 
signif icant elimination for these compounds. 
Metabolic elimination of some glyaidia esters 
As mentioned in the foregoing section no urinary hydroxy 
mercapturic acids derived from an intermediate epoxide have been 
found during the biotransformation of acrylic esters. However, 
the possibi l i ty exists that glycidic esters are poor substrates 
for the glutathione S-transferases. In order to establish the 
ab i l i t y of such epoxyesters to undergo glutathione conjugation 
catalysed by the glutathione S-transferases the glutathione 
depletion and the enhanced mercapturic acid excretion of these 
substrates was investigated. The results, which are collected in 
table V, indicate that indeed these epoxyesters are quite wi l l ing 
to conjugate with glutathione. The enhanced increase of the 
mercapturic acid excretion after a TOTP pretreatment of the 
animals shows indirect ly that the hydrolysis of the epoxyesters 
plays also an important role in the metabolic elimination of these 
compounds. Bearing in mind that the epoxyesters are good 
substrates for the glutathione S-transferases and that no urinary 
mercapturic acids derived from such epoxides have been detected 
after administration of acryl ic esters, i t seems highly unlikely 
that in vivo epoxidation of the acrylates plays a role. 
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TABLE V Depletion of glutathione in vitro and the mercapturic acids excretion in vivo of 
some glycidic esters 
R 2HC^-\;H 
-COOR GSH depletion in rat GSH depletion in liver Mercapturic acid excretion 
liver homogenates homogenates of rats 
pretreated with TOTP 
Pretreatment 
as percentage of dose with TOTP 
(0.2 nunol/kg, mean + S.D., n=4) 
ι 
M 
о 
и 
I R 
H 
R 
H 
R 
CH„ 
H CH„ 
3 3 
C 6 H 5 H CH„ 
26 
22 
7 
19 
38 
31 
34 
52 
11 + 2 
13 + 2 
5 + 1 
4 + 2 
20 + 2 
23 + 2 
10 + 2 
7 + 2 
The GSH depletion is expressed as % decrease of the initial amount. 
I t is of interest to investigate alternative pathways for the 
bioelimination of glycidic esters. To this end the epoxyesters 
were subjected to epoxide hydrolases. Analysis of the reaction 
mixture of vicinal diol derivatives showed that none of the 
substrates was converted into such diols. Structure-activity 
35 studies of Oesch with epoxide hydrolase indicate that trans-
1,2-di- and also t r i - and tetra- substituted epoxides are very 
poor substrates for the epoxide hydrolase system. This may be the 
actual reason why in the present case the trans-l,2-disubstituted 
epoxides f a i l to react. 
Another possible biodégradation of glycidic esters may be 
i n i t i a t ed by a molecular rearrangement. In this context 3-phenyl-
glycidate is of particular interest as i ts rearrangement would 
36 lead to the formation of phenyl pyruvic acid. This a-oxo-
carboxylic acid in turn can be transformed by a decarboxylation 
reaction into phenyl acetaIdehyde which in subsequent steps is 
ultimately converted into phenaceturic acid (glycine conjugate of 
phenylacetic acid). The detection and quantitative determination 
of phenaceturic acid has already been described in chapter 2.4. 
I t was found that after administration of the sodium sal t of 
ß-phenylglycidate to rats (dose 1.6 mmol/kg, n=4) 1.1 + 0.3 % of 
an i .p. dose, and 4.4 + 0.9 % of an oral dose was excreted in 
urine as phenaceturic acid. This finding supports the occurrence 
of an intramolecular rearrangement of B-phenylglycidic acid in 
vivo. 
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SAMENVATTING 
Dit proefschrift handelt over de bestudering van de wijze waarop 
1 ichaamsvreemde chemische stoffen, veelal xenobiotica genoemd, uit 
het organisme worden verwijderd. Dergelijke studies zijn van 
belang omdat de moderne mens in toenemende mate aan xenobiotica 
wordt blootgesteld. In het eerste deel van dit proefschrift wordt 
in kort bestek uiteengezet welke biotransformaties met name 
olefim'sche verbindingen kunnen ondergaan. Glutathion-conjugatie, 
al dan niet gekatalyseerd door de glutathion S-transferases, 
speelt bij dit proces een belangrijke rol. 
De isolatie en identificatie van de mercaptuurzuren, veelal de 
eindproducten van de glutathion-conjugatie, zoals die in de urine 
worden aangetroffen, kunnen informatie verschaffen over de 
gevolgde metabole routes. Structuuropheldering van de mercaptuur-
zuren vormt aldus een belangrijke methodiek in de bestudering van 
biotransformaties. Deze methodiek is veelvuldig gebruikt bij het 
onderzoek naar de biodegradatie van de olefim'sche verbindingen 
beschreven in dit proefschrift. In het tweede deel van dit 
proefschrift wordt het metabolisme van styreen nader 
onderzocht. Van de industrieel belangrijke verbinding styreen was 
reeds bekend dat mercaptuurzuurvorming kon optreden via styreen-
oxide als intermediair. Echter, tot nu toe was slechts één hydroxy-
mercaptuurzuur geïsoleerd. Aangezien de epoxide-ring van styreen-
oxide op twee manieren geopend kan worden deed zich de vraag voor 
of er niet nog een tweede hydroxymercaptuurzuur in vivo gevormd 
zou worden na toediening van styreen of styreenoxide. Niet alleen 
de beide theoretisch verwachte hydroxymercaptuurzuren, maar ook 
nog een ketomercaptuurzuur konden geTdentificeerd worden na 
toediening van styreen (zie figuur 1). Styreenoxide biedt tevens 
de mogelijkheid het stereochemisch aspect in de glutathion-
conjugatie te bestuderen. De additie van het chi ral e tri peptide 
glutathion aan het chiraal styreenoxide resulteert uiteindelijk 
in de vorming van diastereoisomere mercaptuurzuren. De bepaling 
van de verhouding van deze diastereoisomeren, na toediening van 
optisch zuiver en racemisch styreenoxide, leidde tot de conclusie 
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Figuur 1 Zwavelhoudende styreen-metaboliten 
Het kan uitgesloten worden dat de vorming van hydroxy-
mercaptuurzuur IV, na toediening van (2-bromo-ethyl)-
benzeen, verloopt via styreen en/of styreenoxide als 
intermediair 
dat a. de glutathionadditie aan styreenoxide verloopt via een S N2 
mechanisme en b. dat er een enantiomere selectiviteit van de 
glutathion S-transferases optreedt, waarbij S-(-)-styreenoxide 
het betere substraat blijkt te zijn. Na toediening van styreen 
kon op soortgelijke wijze aangetoond worden dat de oxidatie van 
styreen met een hoge mate van stereoselectiviteit geschiedt, 
waarbij het minst mutagene R-(+)-styreenoxide het meest gevormd 
wordt. Niet alleen de mercaptuurzuren werden geïsoleerd als meta-
bolieten van styreen, ook phenacetuurzuur kon aangetoond worden 
als een metaboliet van styreen. Van de twee mogelijke metabole 
routes (zie figuur 2) kon die welke via de omlegging van styreen-
oxide verloopt eenduidig worden aangetoond met behulp van dg-
styreen. 
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CSHJ-CHJCHJOH CsH5-cH2-c;H с6н6-сн2-соон 
O H 
C S HS-CHÍ-C-N-CH 2 -COOH 
VII 
Figuur 2 Vorming van N-(fenylacetyl)glycine 
De kennis omtrent het metabolisme van styreen en styreenoxide 
vormt een hulp bij de opheldering van het mechanisme voor de 
vorming van hydroxymercaptuurzuur IV, na toediening van (2-bromo-
ethyl)benzeen. Dit mercaptuurzuur kan via verschillende routes 
ontstaan, waarbij mogelijkerwijs styreen of styreenoxide als 
intermediair optreden. Aangezien echter slechts één hydroxy-
mercaptuurzuur gevormd werd en dan ook nog datgene dat het minst 
gevormd werd na toediening van styreen of styreenoxide zelf, 
leidt tot de conclusie dat de vorming van het hydroxymercaptuur-
zuur IV na toediening van (2-bromo-ethyl)benzeen, via een 
benzylische oxidatie geschiedt na substitutie van het bromide 
door glutathion. In het derde deel van dit proefschrift worden de 
resultaten van de bestudering van gefunctionaliseerde olefinische 
verbindingen beschreven. Kenmerkend voor deze verbindingen is dat 
zij allen een electronen zuigende groep als substituent bezitten. 
Allereerst werd de aldehydefunctie als substituent aan de dubbele 
band nader bestudeerd. Daar van acroleine en crotonaldehyde reeds 
mercaptuurzuur vorming was aangetoond werd met name kaneel aldehyde 
bestudeerd. In de twee mercaptuurzuren die geïsoleerd werden, was 
de aldehydfunctie geoxideerd tot carbonzuur respectivelijk 
gereduceerd tot methyl eenalcohol (zie figuur 3). 
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Figuur 3 De mercaptuurzuurvorming van kaneelalcohol ( I I ) 
en kaneelaldehyde (I ) 
De mercaptuurzuurvorming van kaneelalcohol ver loopt via kaneel­
aldehyde als i n t e r m e d i a i r . In overeenstemming hiermee werd na 
i n h i b i t i e van alcohol dehydrogenase met pyrazol een verminderde 
mercaptuurzuur vorming van kaneelalcohol waargenomen. Als tweede 
groep werden de α,β onverzadigde ni t r i 11 en onderzocht. De 
st ructuur van de gevonden mercaptuurzuren kan slechts begrepen 
worden door aan te nemen dat naast een d i recte (Hichael) a d d i t i e 
van g l u t a t h i o n ook een o x i d a t i e van de n i t r i l l e n , gevolgs door 
een conjugatie met glutathione optreedt. D i t kon worden bevestigd 
door de enzymatische o x i d a t i e te rermen met 1-phenylimidazol, 
waarna slechts het product van de d i recte a d d i t i e werd geïsoleerd. 
Als laats te werd de carboxylfunct ie als subst i tuent bestudeerd. 
Voor deze groep van verbindingen waren dr ie metabole routes te 
verwachten; hydrolyse gekatalyseerd door carboxylesterase, 
g lu tath ion add i t i e gekatalyseerd door de g lutath ion S-transferase 
en epoxidatie door middel van cyt.P-450 (z ie f iguur 4 ) . 
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De g lu ta th ion conjugatie bleek beïnvloed te worden door de 
hydrolyse van de esters. Door i n h i b i t i e van de carboxylesterase 
met tri(ortho-to'\y'\)phospbaait bleek de mercaptuurzuuruitscheiding 
aanz ien l i j k toe te nemen. Invoering van substi tuenten aan de 
dubbele band van de onverzadigde ester resulteerde i n een aanzien-
l i j k lagere mercaptuurzuuruitscheiding. Eenzelfde verschi jnsel 
werd waargenomen als de ketenlengte i n de alcohol component van de 
acry lester toenam. Aan de mogeli jkheid van een intermediaire 
epoxide b i j de biotransformatie van de onverzadigde ester werd 
ruim aandacht besteed. Echter, zowel de in vitro experimenten als 
mede de in vivo experimenten gaven geen aanwijzing voor het 
optreden van een derge l i j k epoxide. 
R 2 C-OH 
II 
o 
ROH 
R1 R3 carboxy l \ ^ ^ g l u t a t h i o n e 
es te rase /_ \ S-transferase 
R 2 C - O R 
II 
o 
Cyt P45O 
\ 
R1 O R3 
W W 
C - C 
R2 C-OR 
II 
O 
e p o x i d e / N. g lu ta th ione 
hydro lase je ^ S - t r a n s f e r a s e 
R1 R3 О 
3 I I и 
R - C - C - C - O R 
ι ι GS H 
\ i 
THIO ETHERS 
Figuur 4 De mogelijk metabole wegen in de biotransformatie 
van acrylaat esters 
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